Induction of human neuronal cells by defined transcription factors.
- Authors
- Pang, Zhiping P; Yang, Nan; Vierbuchen, Thomas; Ostermeier, Austin; Fuentes, Daniel R; Yang, Troy Q; Citri, Ami; Sebastiano, Vittorio; Marro, Samuele; SΓΌdhof, Thomas C; Wernig, Marius
- Year
- 2011
- Journal
- Nature
- PMID
- 21617644
- DOI
- 10.1038/nature10202
- PMCID
- PMC3159048
Somatic cell nuclear transfer, cell fusion, or expression of lineage-specific factors have been shown to induce cell-fate changes in diverse somatic cell types. We recently observed that forced expression of a combination of three transcription factors, Brn2 (also known as Pou3f2), Ascl1 and Myt1l, can efficiently convert mouse fibroblasts into functional induced neuronal (iN) cells. Here we show that the same three factors can generate functional neurons from human pluripotent stem cells as early as 6βdays after transgene activation. When combined with the basic helix-loop-helix transcription factor NeuroD1, these factors could also convert fetal and postnatal human fibroblasts into iN cells showing typical neuronal morphologies and expressing multiple neuronal markers, even after downregulation of the exogenous transcription factors. Importantly, the vast majority of human iN cells were able to generate action potentials and many matured to receive synaptic contacts when co-cultured with primary mouse cortical neurons. Our data demonstrate that non-neural human somatic cells, as well as pluripotent stem cells, can be converted directly into neurons by lineage-determining transcription factors. These methods may facilitate robust generation of patient-specific human neurons for in vitro disease modelling or future applications in regenerative medicine.
Rapid generation of functional neurons from human ES cellsa, Four days after induction, ES-iN cells exhibited bipolar neuronal morphologies. bβc, Eight days after induction, ES-iN cells expressed Tuj1 (b) and MAP2 (c). d, Spontaneous action potentials presumably caused by membrane potential fluctuations recorded from an ES-iN cell 6 days after induction. Arrow: pronounced AHP. e, Representative traces of action potentials in response to step current injections 15 days after induction. Membrane potential was maintained at ~ β63mV. f, Quantification of intrinsic membrane properties in control ES cells (0 day) before and after viral transduction. membrane input resistance (Rin), resting membrane potential (RMP), capacitance (Cm), after hyperpolarization potentials (AHP). Scale bars: 10Β΅m (a,b,c). Numbers of cells recorded are labeled in the bars. Note the heterogeneity of the parameters (see also Suppl. Fig. 1). Data are presented with meanΒ±SEM. * p<0.05.
NeuroD1 increases reprogramming efficiency in primary human fetal fibroblastsa, Quantification of Tuj1-positive BAM-iN cells with indicated factors, 3 weeks after dox. bβc, Three weeks after dox BAM+NeuroD1 iN cells exhibited neuronal morphologies (b) and expressed Tuj1 (c) . dβf, iN cells expressed NeuN (d,) PSA-NCAM (e), and MAP2 (f) 2 weeks after dox. gβh, An iN cell expressing MAP2 (g) and synapsin (h) 4 weeks after dox and co-cultured with primary astrocytes. i, Single cell gene expression profiling using Fluidigm dynamic arrays. Rows represent the evaluated genes and columns represent individual cells. Heatmap (blue to red) represents the threshold Ct values as indicated. Data in (a) are presented as meanΒ±SD. Scale bars: 100 Β΅m (b, c), 10 Β΅m (dβh).
Membrane properties of fibroblast iN cellsa, Quantification of Tuj1-positive neuronal cells from HFFs (line HFF-A) 3 weeks after dox or HPFs (line HPF-B) 4 weeks after dox. N=3 independent experiments. b, Patch clamp recording was conducted on HFF-iN cells identified by EGFP fluorescence and DIC microcopy. c, Representative traces of membrane potentials in response to step current injections (lower panel) from an HFF-iN cell 19 days after dox. Membrane potential was maintained at ~ β63 mV. d, Representative traces of membrane currents recorded with a ramp protocol (lower panel). Fast activating and inactivating Na+ currents were prominent. Three traces are shown superimposed. eβg, HPF-iN cells express Tuj1 (red) and NeuN (green) (e), Neurofilament (green) (f) and MAP2 (green) (g). h, Representative traces of membrane potentials in response to step current injections in HPF-iN cells. Action potentials were generated in cultures without glia. i, Representative traces of membrane currents recorded following a ramp protocol (lower panel) in HPF-iN cells. The Na+ currents could be blocked by TTX. Data in (a) are presented as meanΒ±SD. Scale bars: 10 Β΅m (a, eβg).
Synaptic responses of HFF-iN cellsa, An HFF-iN cell expressing EGFP co-cultured with mouse cortical neurons at day 35 after dox. b, Synapsin positive puncta co-localize with neurites extending from HFF-iN cells (arrow heads). c, Thirty-five days after dox, spontaneous PSCs were recorded in HFF-iN cells. d, The slow responses could be blocked by PTX. Bursting events of EPSCs were recorded in the presence of PTX. The insert shows the fast kinetics of the responses. e, In the presence of PTX and CNQX (50 Β΅M), no spontaneous activities were observed. f, Evoked postsynaptic responses. Four traces were super imposed. Sti. = stimulation. g, In the presence of PTX, electric stimulation evoked fast-kinetic excitatory PSCs (EPSCs). h, No evoked synaptic responses were observed in the presence of PTX and CNQX. Scale bars: 100 Β΅m (a); 10Β΅m (b).
No entities extracted from this document yet.
No uploaded files.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Celebrating 25 years of the Sakiyama-Elbert lab: a look back on the evolution of neural biomaterials and future directions for the field. | Wood MD et al. | β | 2026 | β |
| Direct neuronal reprogramming: emerging therapeutic strategies for neurodegenerative disorders. | Tyagi A et al. | β | 2026 | β |
| Disc-Derived Induced Pluripotent Stem Cells and Environmental Cues for Nucleus Pulposus Regeneration. | Laagland LT et al. | β | 2026 | β |
| Identification of Skin Multicellular Reprogramming Factors as Potential Treatment for Nonhealing Diabetic Foot Ulcers. | Abouhashem AS et al. | β | 2026 | β |
| Lipid membrane remodeling by myristic acid treatment reverses Parkinson's disease Ξ±-synuclein phenotypes in patient neurons. | Pacheco JA et al. | β | 2026 | β |
| Mettl3 promotes reprogramming and axonogenesis of induced retinal ganglion cells. | Zhang K et al. | β | 2026 | β |
| Sphingolipid-neutralizing molecular therapy reduces psychosine cytotoxicity in Krabbe disease. | Begum S et al. | β | 2026 | β |
| The application of directly induced neurons into neurodegenerative disease modeling. | Matsumoto K et al. | β | 2026 | β |
| The role of transcription-coupled nucleotide excision repair (TC-NER) during mammalian forebrain development. | Patel S et al. | β | 2026 | β |
| Unraveling the Morphological and Functional Maturation Mechanisms Underlying Human Neural Development Using iPSCs-Derived Neuronal Model. | Tian Y et al. | β | 2026 | β |
| Adult hippocampal neurogenesis: New avenues for treatment of brain disorders. | Chen L et al. | β | 2025 | β |
| Advances in Stem Cell Therapy for Huntington's Disease: A Comprehensive Literature Review. | Shah S et al. | β | 2025 | β |
| A Positive Feedback DNA-PK/MYT1L-CXCR1-ERK1/2 Proliferative Signaling Loop in Glioblastoma. | Wang B et al. | β | 2025 | β |
| Ascl1 in Retinal Regeneration: From Neuronal Fate Determination to Reprogramming Mechanisms. | Yan L et al. | β | 2025 | β |
| Cell-based regenerative and rejuvenation strategies for treating neurodegenerative diseases. | Deng S et al. | β | 2025 | β |
| Cell fate acquisition and reprogramming by the proneural transcription factor ASCL1. | Lundie-Brown J et al. | β | 2025 | β |
| Cell reprogramming: methods, mechanisms and applications. | Zhu F et al. | β | 2025 | β |
| Current Development of iPSC-Based Modeling in Neurodegenerative Diseases. | Guo X et al. | β | 2025 | β |
| Direct reprogramming of human fibroblasts into hair-inducing dermal papilla cell-like cells by a single small molecule. | Zeng Q et al. | β | 2025 | β |
| Direct transdifferentiation of tumorigenic melanoma cells induces tumor cell reversion. | Wang Y et al. | β | 2025 | β |
| Extracellular lactate improves neurogenesis by modulating H3K9 lactylation and SnoN expression under hypoxic conditions. | Xu W et al. | β | 2025 | β |
| From Physiology to Pathology of Astrocytes: Highlighting Their Potential as Therapeutic Targets for CNS Injury. | Yuan Y et al. | β | 2025 | β |
| Functional Validation of Alcohol Dependence-Associated <i>FYN</i> Variants Using Gene Editing and Stem Cell Study Approaches. | Cakir B et al. | β | 2025 | β |
| Generation of Glutamatergic Human Neurons from Induced Pluripotent Stem Cells. | Rizalar FS et al. | β | 2025 | β |
| Glial Cell Reprogramming in Ischemic Stroke: A Review of Recent Advancements and Translational Challenges. | GreΘiΘΔ A et al. | β | 2025 | β |
| Identifying Age-Modulating Compounds Using a Novel Computational Framework for Evaluating Transcriptional Age. | Zhang C et al. | β | 2025 | β |
| Investigating the ageing-Parkinson's disease nexus: standardisation of in vitro models and techniques by the PD-AGE network. | Bury AG et al. | β | 2025 | β |
| In Vitro and In Vivo Direct Reprogramming of Astrocytes to Induced-Neurons. | Papadimitriou E et al. | β | 2025 | β |
| Lysosome repair fails in ageing and Alzheimer's disease. | Vrancx C et al. | β | 2025 | β |
| Modulation of cell fate by shock wave therapy in ischaemic heart disease. | Graber M et al. | β | 2025 | β |
| Modulation of pain sensitivity by Ascl1- and Lhx6-dependent GABAergic neuronal function in streptozotocin diabetic mice. | Hwang SM et al. | β | 2025 | β |
| Mutations of schizophrenia risk gene SETD1A dysregulate synaptic function in human neurons. | Su X et al. | β | 2025 | β |
| NEUROD1 efficiently converts peripheral blood cells into neurons with partial reprogramming by pluripotency factors. | Saito Y et al. | β | 2025 | β |
| Proteostasis and lysosomal repair deficits in transdifferentiated neurons of Alzheimer's disease. | Chou CC et al. | β | 2025 | β |
| Reprogramming of skin fibroblasts by 3D spheroid culture promotes peripheral nerve regeneration via the ID3/semaphorin7a pathway. | Tan X et al. | β | 2025 | β |
| Stearoyl-CoA desaturase inhibition normalizes brain lipid saturation, Ξ±-synuclein homeostasis, and motor function in mutant Gba1-Parkinson mice. | Nuber S et al. | β | 2025 | β |
| Stem cell therapy use in patients with dementia: a systematic review. | Uwishema O et al. | β | 2025 | β |
| Stratification of enterochromaffin cells by single-cell expression analysis. | Song Y et al. | β | 2025 | β |
| Tracing mitochondrial marks of neuronal aging in iPSCs-derived neurons and directly converted neurons. | Varghese N et al. | β | 2025 | β |
| Transcriptional enhancers in human neuronal differentiation provide clues to neuronal disorders. | Yoshihara M et al. | β | 2025 | β |
| A cellular identity crisis? Plasticity changes during aging and rejuvenation. | Gorelov R et al. | β | 2024 | β |
| Age- and disease-related autophagy impairment in Huntington disease: New insights from direct neuronal reprogramming. | Luo C et al. | β | 2024 | β |
| Analyses of the autism-associated neuroligin-3 R451C mutation in human neurons reveal a gain-of-function synaptic mechanism. | Wang L et al. | β | 2024 | β |
| An integrated in vitro human iPSCs-derived neuron and in vivo animal approach for preclinical screening of anti-seizure compounds. | Zhao C et al. | β | 2024 | β |
| ASCL1-mediated direct reprogramming: converting ventral midbrain astrocytes into dopaminergic neurons for Parkinson's disease therapy. | Yong SH et al. | β | 2024 | β |
| Chromatin accessibility: biological functions, molecular mechanisms and therapeutic application. | Chen Y et al. | β | 2024 | β |
| Comparing stem cells, transdifferentiation and brain organoids as tools for psychiatric research. | Bellon A | β | 2024 | β |
| Controlling the Expression Level of the Neuronal Reprogramming Factors for a Successful Reprogramming Outcome. | Mseis-Jackson N et al. | β | 2024 | β |
| Cultivation, Differentiation, and Lentiviral Transduction of Human-Induced Pluripotent Stem Cell (hiPSC)-Derived Glutamatergic Neurons for Studying Human Tau. | Buchholz S et al. | β | 2024 | β |
| Direct neuronal reprogramming of NDUFS4 patient cells identifies the unfolded protein response as a novel general reprogramming hurdle. | Sonsalla G et al. | β | 2024 | β |
| Ethnic-specific genetic susceptibility loci for endometriosis in Taiwanese-Han population: a genome-wide association study. | Sheu JJ et al. | β | 2024 | β |
| Forskolin-driven conversion of human somatic cells into induced neurons through regulation of the cAMP-CREB1-JNK signaling. | Wang G et al. | β | 2024 | β |
| Forward programming of hiPSCs towards beta-like cells using Ngn3, Pdx1, and MafA. | Jeyagaran A et al. | β | 2024 | β |
| Functional genomics and small molecules in mitochondrial neurodevelopmental disorders. | Calame DG et al. | β | 2024 | β |
| Genome-wide screening reveals essential roles for HOX genes and imprinted genes during caudal neurogenesis of human embryonic stem cells. | Kinreich S et al. | β | 2024 | β |
| hPSC-Derived Astrocytes at the Forefront of Translational Applications in Neurological Disorders. | Jovanovic VM et al. | β | 2024 | β |
| Introduction to stem cell biology and its role in treating neurologic disorders. | Parmar M et al. | β | 2024 | β |
| In vitro human cell culture models in a bench-to-bedside approach to epilepsy. | DanaΔΓkovΓ‘ Ε et al. | β | 2024 | β |
| Lineage Reprogramming: Genetic, Chemical, and Physical Cues for Cell Fate Conversion with a Focus on Neuronal Direct Reprogramming and Pluripotency Reprogramming. | Umeyama T et al. | β | 2024 | β |
| Modeling APOE Ξ΅4 familial Alzheimer's disease in directly converted 3D brain organoids. | Kim Y et al. | β | 2024 | β |
| Modeling common and rare genetic risk factors of neuropsychiatric disorders in human induced pluripotent stem cells. | Muhtaseb AW et al. | β | 2024 | β |
| Neural crest precursors from the skin are the primary source of directly reprogrammed neurons. | Belair-Hickey JJ et al. | β | 2024 | β |
| NEUROD1: transcriptional and epigenetic regulator of human and mouse neuronal and endocrine cell lineage programs. | Pavlinkova G et al. | β | 2024 | β |
| Neuroendocrine prostate cancer drivers SOX2 and BRN2 confer differential responses to imipridones ONC201, ONC206, and ONC212 in prostate cancer cell lines. | Purcell C et al. | β | 2024 | β |
| Neuronal conversion from glia to replenish the lost neurons. | Liang S et al. | β | 2024 | β |
| Novel Approaches to Studying SLC13A5 Disease. | Beltran AS | β | 2024 | β |
| Oncogenic Role of SATB2 In Vitro: Regulator of Pluripotency, Self-Renewal, and Epithelial-Mesenchymal Transition in Prostate Cancer. | Yu W et al. | β | 2024 | β |
| Patient-derived neuron model: Capturing age-dependent adult-onset degenerative pathology in Huntington's disease. | Oh YM et al. | β | 2024 | β |
| Phospho-regulation of ASCL1-mediated chromatin opening during cellular reprogramming. | Azzarelli R et al. | β | 2024 | β |
| Polygenic risk for alcohol use disorder affects cellular responses to ethanol exposure in a human microglial cell model. | Li X et al. | β | 2024 | β |
| Post-transcriptional mechanisms controlling neurogenesis and direct neuronal reprogramming. | Papadimitriou E et al. | β | 2024 | β |
| Probing the molecular and cellular pathological mechanisms of schizophrenia using human induced pluripotent stem cell models. | Sebastian R et al. | β | 2024 | β |
| Reactive gliosis in traumatic brain injury: a comprehensive review. | Amlerova Z et al. | β | 2024 | β |
| Reprogramming of astrocytes and glioma cells into neurons for central nervous system repair and glioblastoma therapy. | Wei J et al. | β | 2024 | β |
| Resident immune responses to spinal cord injury: role of astrocytes and microglia. | Brockie S et al. | β | 2024 | β |
| RFX4 is an intrinsic factor for neuronal differentiation through induction of proneural genes POU3F2 and NEUROD1. | Choi W et al. | β | 2024 | β |
| RXR nuclear receptor signaling modulates lipid metabolism and triggers lysosomal clearance of alpha-synuclein in neuronal models of synucleinopathy. | Tripathi A et al. | β | 2024 | β |
| Screens in aging-relevant human ALS-motor neurons identify MAP4Ks as therapeutic targets for the disease. | Liu ML et al. | β | 2024 | β |
| Single-cell Profiling of Reprogrammed Human Neural Stem Cells Unveils High Similarity to Neural Progenitors in the Developing Central Nervous System. | Spathopoulou A et al. | β | 2024 | β |
| Small molecules reprogram reactive astrocytes into neuronal cells in the injured adult spinal cord. | Tan Z et al. | β | 2024 | β |
| Stem cell therapy for the treatment of psychiatric disorders: a real hope for the next decades. | Villanueva R | β | 2024 | β |
| Strategies for modeling aging and age-related diseases. | Jothi D et al. | β | 2024 | β |
| Study on the therapeutic potential of induced neural stem cells for Alzheimer's disease in mice. | Ji Q et al. | β | 2024 | β |
| The Goldfish Genome and Its Utility for Understanding Gene Regulation and Vertebrate Body Morphology. | Omori Y et al. | β | 2024 | β |
| The proneural factors Ascl1a and Ascl1b contribute to the terminal differentiation of dopaminergic GABAergic dual transmitter neurons in zebrafish. | AltbΓΌrger C et al. | β | 2024 | β |
| Transcription factor dynamics, oscillation, and functions in human enteroendocrine cell differentiation. | Singh PNP et al. | β | 2024 | β |
| 2p25.3 microduplications involving MYT1L: further phenotypic characterization through an assessment of 16 new cases and a literature review. | Bouassida M et al. | β | 2023 | β |
| 5. Collaborative Study on the Genetics of Alcoholism: Functional genomics. | Gameiro-Ros I et al. | β | 2023 | β |
| A cutting-edge strategy for spinal cord injury treatment: resident cellular transdifferentiation. | Fang YM et al. | β | 2023 | β |
| Alcohol reverses the effects of KCNJ6 (GIRK2) noncoding variants on excitability of human glutamatergic neurons. | Popova D et al. | β | 2023 | β |
| An engineered Sox17 induces somatic to neural stem cell fate transitions independently from pluripotency reprogramming. | Weng M et al. | β | 2023 | β |
| A transcription factor atlas of directed differentiation. | Joung J et al. | β | 2023 | β |
| BET Inhibitors Target the SCLC-N Subtype of Small-Cell Lung Cancer by Blocking NEUROD1 Transactivation. | Chen H et al. | β | 2023 | β |
| Characterization by Gene Expression Analysis of Two Groups of Dopaminergic Cells Isolated from the Mouse Olfactory Bulb. | Casciano F et al. | β | 2023 | β |
| Chromodomain helicase DNA binding protein 4 in cell fate decisions. | Laureano A et al. | β | 2023 | β |
| Conserved transcription factors promote cell fate stability and restrict reprogramming potential in differentiated cells. | Missinato MA et al. | β | 2023 | β |
| Deep learning predicts the impact of regulatory variants on cell-type-specific enhancers in the brain. | Zheng A et al. | β | 2023 | β |
| Direct cellular reprogramming and transdifferentiation of fibroblasts on wound healing-Fantasy or reality? | Du J et al. | β | 2023 | β |
| Direct Conversion of Fibroblast into Neurons for Alzheimer's Disease Research: A Systematic Review. | Sattarov R et al. | β | 2023 | β |
| Endothelial cell direct reprogramming: Past, present, and future. | Cho S et al. | β | 2023 | β |
| Engineering Female Germline Stem Cells with Exocytotic Polymer Dots. | Luo Y et al. | β | 2023 | β |
| Extracellular vesicles and their microRNA cargo in ischaemic stroke. | Fullerton JL et al. | β | 2023 | β |
| Forward programming of hiPSCs towards beta-like cells using Ngn3, Pdx1, and MafA | Jeyagaran A et al. | β | 2023 | β |
| Gene Editing and Human iPSCs in Cardiovascular and Metabolic Diseases. | Giallongo S et al. | β | 2023 | β |
| Genetic variants of NEUROD1 target genes are associated with clinical outcomes of small-cell lung cancer patients. | Lee S et al. | β | 2023 | β |
| Human Induced Pluripotent Stem Cell-Derived Pericytes as Scalable and Editable Source to Study Direct Lineage Reprogramming Into Induced Neurons. | Menon R et al. | β | 2023 | β |
| Human pluripotent stem cell (hPSC) and organoid models of autism: opportunities and limitations. | Kilpatrick S et al. | β | 2023 | β |
| Insights and applications of direct neuronal reprogramming. | Schaukowitch K et al. | β | 2023 | β |
| Mechanisms and biotechnological applications of transcription factors. | He H et al. | β | 2023 | β |
| Moving CNS axon growth and regeneration research into human model systems. | Lear BP et al. | β | 2023 | β |
| NeuroD1-GPX4 signaling leads to ferroptosis resistance in hepatocellular carcinoma. | Huang P et al. | β | 2023 | β |
| Patient-Derived Cellular Models for Polytarget Precision Medicine in Pantothenate Kinase-Associated Neurodegeneration. | Γlvarez-CΓ³rdoba M et al. | β | 2023 | β |
| PTBP2 attenuation facilitates fibroblast to neuron conversion by promoting alternative splicing of neuronal genes. | Zhu B et al. | β | 2023 | β |
| Radial stem astrocytes (aka neural stem cells): Identity, development, physio-pathology, and therapeutic potential. | Yeh CY et al. | β | 2023 | β |
| Recent advancement in therapeutic strategies for Alzheimer's disease: Insights from clinical trials. | Khan T et al. | β | 2023 | β |
| Reduction of Intracellular Tension and Cell Adhesion Promotes Open Chromatin Structure and Enhances Cell Reprogramming. | Soto J et al. | β | 2023 | β |
| Restoring tumor immunogenicity with dendritic cell reprogramming. | Zimmermannova O et al. | β | 2023 | β |
| Retinal Ganglion Cells in a Dish: Current Strategies and Recommended Best Practices for Effective In Vitro Modeling of Development and Disease. | Huang KC et al. | β | 2023 | β |
| Specific Methyl-CpG Configurations Define Cell Identity through Gene Expression Regulation. | Improda T et al. | β | 2023 | β |
| Strategies and mechanisms of neuronal reprogramming. | Wan Y et al. | β | 2023 | β |
| The latest role of nerve-specific splicing factor PTBP1 in the transdifferentiation of glial cells into neurons. | Chen XD et al. | β | 2023 | β |
| Use of <i>in vitro</i> derived human neuronal models to study host-parasite interactions of <i>Toxoplasma gondii</i> in neurons and neuropathogenesis of chronic toxoplasmosis. | Halonen SK | β | 2023 | β |
| Virtual Screening-Based Drug Development for the Treatment of Nervous System Diseases. | Li Q et al. | β | 2023 | β |
| Whole Cell Patch Clamp Electrophysiology in Human Neuronal Cells. | Gabriel R et al. | β | 2023 | β |
| Accelerated neuronal aging <i>in vitro</i> βΌmelting watch βΌ. | Inagaki E et al. | β | 2022 | β |
| Adult neurogenesis and the molecular signalling pathways in brain: the role of stem cells in adult hippocampal neurogenesis. | Bagheri-Mohammadi S | β | 2022 | β |
| Age-related Huntington's disease progression modeled in directly reprogrammed patient-derived striatal neurons highlights impaired autophagy. | Oh YM et al. | β | 2022 | β |
| An Improved Method to Generate Human Induced Astrocytes. | Drouin-Ouellet J | β | 2022 | β |
| APOE Ξ΅4-dependent effects on the early amyloid pathology in induced neuronsΒ of patients with Alzheimer's disease. | Kim H et al. | β | 2022 | β |
| Application and prospects of high-throughput screening for <i>in vitro</i> neurogenesis. | Zhang SY et al. | β | 2022 | β |
| Application and prospects of somatic cell reprogramming technology for spinal cord injury treatment. | Yang R et al. | β | 2022 | β |
| Astrocyte Reprogramming in Stroke: Opportunities and Challenges. | Peng Z et al. | β | 2022 | β |
| Biomaterial and tissue-engineering strategies for the treatment of brain neurodegeneration. | Martinez B et al. | β | 2022 | β |
| Cell models for Down syndrome-Alzheimer's disease research. | Wu Y et al. | β | 2022 | β |
| Chemically-induced osteogenic cells for bone tissue engineering and disease modeling. | Yoon JY et al. | β | 2022 | β |
| Chemical Replacement of Noggin with Dorsomorphin Homolog 1 for Cost-Effective Direct Neuronal Conversion. | BΓΆhnke L et al. | β | 2022 | β |
| Circuit formation in the adult brain. | Seng C et al. | β | 2022 | β |
| Differentiation of Human Induced Pluripotent Stem Cells into Cortical Neurons to Advance Precision Medicine. | Silva MC et al. | β | 2022 | β |
| Differentiation of pluripotent stem cells for modeling human skin development and potential applications. | Oceguera-Yanez F et al. | β | 2022 | β |
| Direct Conversion of Cell Fate and Induced Endothelial Cells. | Han JK et al. | β | 2022 | β |
| Direct neuronal reprogramming: Fast forward from new concepts toward therapeutic approaches. | Bocchi R et al. | β | 2022 | β |
| Disease Modeling of Neurodegenerative Disorders Using Direct Neural Reprogramming. | Legault EM et al. | β | 2022 | β |
| Dynamics and Pathways of Chromosome Structural Organizations during Cell Transdifferentiation. | Chu X et al. | β | 2022 | β |
| Early Deletion of <i>Neurod1</i> Alters Neuronal Lineage Potential and Diminishes Neurogenesis in the Inner Ear. | Filova I et al. | β | 2022 | β |
| EGF signaling promotes the lineage conversion of astrocytes into oligodendrocytes. | Liu X et al. | β | 2022 | β |
| Endothelial cells regulate astrocyte to neural progenitor cell trans-differentiation in a mouse model of stroke. | Li W et al. | β | 2022 | β |
| Gadd45g, A Novel Antidepressant Target, Mediates Metformin-Induced Neuronal Differentiation of Neural Stem Cells Via DNA Demethylation. | Zhang L et al. | β | 2022 | β |
| Generation and Application of Directly Reprogrammed Endothelial Cells. | Jung C et al. | β | 2022 | β |
| Harnessing the Power of Stem Cell Models to Study Shared Genetic Variants in Congenital Heart Diseases and Neurodevelopmental Disorders. | Chang X et al. | β | 2022 | β |
| Human-Induced Pluripotent Stem Cell-Based Models for Studying Sex-Specific Differences in Neurodegenerative Diseases. | Kiris E | β | 2022 | β |
| Human iPSC-Derived Neural Models for Studying Alzheimer's Disease: from Neural Stem Cells to Cerebral Organoids. | Barak M et al. | β | 2022 | β |
| Identification of TAZ as the essential molecular switch in orchestrating SCLC phenotypic transition and metastasis. | Jin Y et al. | β | 2022 | β |
| Impact of Mitochondrial A3243G Heteroplasmy on Mitochondrial Bioenergetics and Dynamics of Directly Reprogrammed MELAS Neurons. | Lin DS et al. | β | 2022 | β |
| Induced Dopaminergic Neurons for Parkinson's Disease Therapy: Targeting the Striatum or Midbrain/Substantia Nigra Pars Compacta? | Xu H et al. | β | 2022 | β |
| Inducing human retinal pigment epithelium-like cells from somatic tissue. | Woogeng IN et al. | β | 2022 | β |
| Limitations and challenges of direct cell reprogramming in vitro and in vivo. | Zhang YX et al. | β | 2022 | β |
| Lipase regulation of cellular fatty acid homeostasis as a Parkinson's disease therapeutic strategy. | Fanning S et al. | β | 2022 | β |
| Long-term morphological and functional dynamics of human stem cell-derived neuronal networks on high-density micro-electrode arrays. | Habibey R et al. | β | 2022 | β |
| Mapping cis-regulatory elements in human neurons links psychiatric disease heritability and activity-regulated transcriptional programs. | Sanchez-Priego C et al. | β | 2022 | β |
| Microfluidics for Neuronal Cell and Circuit Engineering. | Habibey R et al. | β | 2022 | β |
| MicroRNA Roles in Cell Reprogramming Mechanisms. | Pascale E et al. | β | 2022 | β |
| miRNA-338-3p inhibits glioma cell proliferation and progression by targeting MYT1L. | Yu Z et al. | β | 2022 | β |
| Modeling Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes Syndrome Using Patient-Derived Induced Neurons Generated by Direct Reprogramming. | Povea-Cabello S et al. | β | 2022 | β |
| Motor neuron-derived induced pluripotent stem cells as a drug screening platform for amyotrophic lateral sclerosis. | AmorΓ³s MA et al. | β | 2022 | β |
| Myt1l haploinsufficiency leads to obesity and multifaceted behavioral alterations in mice. | WΓΆhr M et al. | β | 2022 | β |
| Neural stem cell transplantation alleviates functional cognitive deficits in a mouse model of tauopathy. | Zhang HA et al. | β | 2022 | β |
| Nuclear Architecture in the Nervous System. | Ito K et al. | β | 2022 | β |
| Optimized splitting of mixed-species RNA sequencing data. | Song X et al. | β | 2022 | β |
| Parkinson's disease motor symptoms rescue by CRISPRa-reprogramming astrocytes into GABAergic neurons. | Giehrl-Schwab J et al. | β | 2022 | β |
| Past, Present, and Future of Direct Cell Reprogramming. | Ahlenius H | β | 2022 | β |
| Patient-Derived InΒ Vitro Models of Microglial Function and Synaptic Engulfment in Schizophrenia. | Sheridan SD et al. | β | 2022 | β |
| Pharmacological Perturbation of Mechanical Contractility Enables Robust Transdifferentiation of Human Fibroblasts into Neurons. | He ZQ et al. | β | 2022 | β |
| Pharmacotherapy alleviates pathological changes in human direct reprogrammed neuronal cell model of myotonic dystrophy type 1. | Eltahir MK et al. | β | 2022 | β |
| Postnatal age-differential ASD-like transcriptomic, synaptic, and behavioral deficits in Myt1l-mutant mice. | Kim S et al. | β | 2022 | β |
| Reprogramming of Rat Fibroblasts into Induced Neurons by Small-Molecule Compounds In Vitro and In Vivo. | Wang X et al. | β | 2022 | β |
| Revealing the Impact of Mitochondrial Fitness During Early Neural Development Using Human Brain Organoids. | Romero-Morales AI et al. | β | 2022 | β |
| Somatic Lineage Reprogramming. | Shelby H et al. | β | 2022 | β |
| Spinal motor neuron transplantation to enhance nerve reconstruction strategies: Towards a cell therapy. | Bazarek S et al. | β | 2022 | β |
| Stem Cells as a Potential Therapeutic Option for Treating Neurodegenerative Diseases. | Aishwarya L et al. | β | 2022 | β |
| Stem cell therapy for Alzheimer's disease: An overview of experimental models and reality. | Qin C et al. | β | 2022 | β |
| Strategies of pluripotent stem cell-based therapy for retinal degeneration: update and challenges. | Maeda T et al. | β | 2022 | β |
| Targeting PTB for Glia-to-Neuron Reprogramming In Vitro and In Vivo for Therapeutic Development in Neurological Diseases. | Contardo M et al. | β | 2022 | β |
| The autism risk factor CHD8 is a chromatin activator in human neurons and functionally dependent on the ERK-MAPK pathway effector ELK1. | Haddad Derafshi B et al. | β | 2022 | β |
| The bHLH Transcription Factors in Neural Development and Therapeutic Applications for Neurodegenerative Diseases. | Lee DG et al. | β | 2022 | β |
| The Efficiency of Direct Maturation: the Comparison of Two hiPSC Differentiation Approaches into Motor Neurons. | Schaefers C et al. | β | 2022 | β |
| Therapeutic potential of glial cell line-derived neurotrophic factor and cell reprogramming for hippocampal-related neurological disorders. | Chiavellini P et al. | β | 2022 | β |
| The role of senescence in cellular plasticity: Lessons from regeneration and development and implications for age-related diseases. | Ring NAR et al. | β | 2022 | β |
| Tracking connectivity maps in human stem cell-derived neuronal networks by holographic optogenetics. | Schmieder F et al. | β | 2022 | β |
| Transcription Factors with Targeting Potential in Gliomas. | Giannopoulou AI et al. | β | 2022 | β |
| TRANSDIRE: data-driven direct reprogramming by a pioneer factor-guided trans-omics approach. | Eguchi R et al. | β | 2022 | β |
| Transient nuclear deformation primes epigenetic state and promotes cell reprogramming. | Song Y et al. | β | 2022 | β |
| Using 2D and 3D pluripotent stem cell models to study neurotropic viruses. | LaNoce E et al. | β | 2022 | β |
| Age-dependent instability of mature neuronal fate in induced neurons from Alzheimer's patients. | Mertens J et al. | β | 2021 | β |
| Alzheimer's disease and its treatment by different approaches: A review. | Srivastava S et al. | β | 2021 | β |
| A MYT1L syndrome mouse model recapitulates patient phenotypes and reveals altered brain development due to disrupted neuronal maturation. | Chen J et al. | β | 2021 | β |
| ANANSE: an enhancer network-based computational approach for predicting key transcription factors in cell fate determination. | Xu Q et al. | β | 2021 | β |
| A quantitative model of cellular decision making in direct neuronal reprogramming. | Merlevede A et al. | β | 2021 | β |
| Balancing serendipity and reproducibility: Pluripotent stem cells as experimental systems for intellectual and developmental disorders. | Anderson NC et al. | β | 2021 | β |
| Bioinformatics analysis of Myelin Transcription Factor 1. | Ding H et al. | β | 2021 | β |
| Brain Repair by Cell Replacement via In Situ Neuronal Reprogramming. | Qian H et al. | β | 2021 | β |
| Cell Transdifferentiation and Reprogramming in Disease Modeling: Insights into the Neuronal and Cardiac Disease Models and Current Translational Strategies. | Kalra RS et al. | β | 2021 | β |
| Cellular Models and High-Throughput Screening for Genetic Causality of Intellectual Disability. | Fell CW et al. | β | 2021 | β |
| Conversion of mouse embryonic fibroblasts into neural crest cells and functional corneal endothelia by defined small molecules. | Pan SH et al. | β | 2021 | β |
| CRISPR-activated patient fibroblasts for modeling of familial Alzheimer's disease. | Inoue K | β | 2021 | β |
| Cross-platform validation of neurotransmitter release impairments in schizophrenia patient-derived <i>NRXN1</i>-mutant neurons. | Pak C et al. | β | 2021 | β |
| Decoding Neuronal Diversification by Multiplexed Single-cell RNA-Seq. | LuginbΓΌhl J et al. | β | 2021 | β |
| Direct Cell Reprogramming of Mouse Fibroblasts into Functional Astrocytes Using Lentiviral Overexpression of the Transcription Factors NFIA, NFIB, and SOX9. | Qiu B et al. | β | 2021 | β |
| Direct Differentiation of Functional Neurons from Human Pluripotent Stem Cells (hPSCs). | Hu R et al. | β | 2021 | β |
| Directly Reprogrammed Human Neurons to Understand Age-Related Energy Metabolism Impairment and Mitochondrial Dysfunction in Healthy Aging and Neurodegeneration. | Gudenschwager C et al. | β | 2021 | β |
| Directly reprogrammed Huntington's disease neural precursor cells generate striatal neurons exhibiting aggregates and impaired neuronal maturation. | Monk R et al. | β | 2021 | β |
| Direct Neuronal Reprogramming: Bridging the Gap Between Basic Science and Clinical Application. | Vasan L et al. | β | 2021 | β |
| Direct Reprogramming of Fibroblasts to Astrocytes Using Small Molecules. | Tian E et al. | β | 2021 | β |
| Direct Reprogramming of Somatic Cells to Neurons: Pros and Cons of Chemical Approach. | Mollinari C et al. | β | 2021 | β |
| Efficient generation of dopaminergic induced neuronal cells with midbrain characteristics. | Ng YH et al. | β | 2021 | β |
| Functional Assessment of Direct Reprogrammed Neurons In Vitro and In Vivo. | Kidnapillai S et al. | β | 2021 | β |
| Functional Characterization of Human Pluripotent Stem Cell-Derived Models of the Brain with Microelectrode Arrays. | Pelkonen A et al. | β | 2021 | β |
| Generation of Human Neurons by microRNA-Mediated Direct Conversion of Dermal Fibroblasts. | Church VA et al. | β | 2021 | β |
| Generation of Induced Dopaminergic Neurons from Human Fetal Fibroblasts. | Legault EM et al. | β | 2021 | β |
| Genetic control of retinal ganglion cell genesis. | Lyu J et al. | β | 2021 | β |
| Genome-wide hypermethylation is closely associated with abnormal expression of genes involved in neural development in induced pluripotent stem cells derived from a Down syndrome mouse model. | Xi JJ et al. | β | 2021 | β |
| Human cell transformation by combined lineage conversion and oncogene expression. | Sahu B et al. | β | 2021 | β |
| Human iPSC-Derived Neurons as A Platform for Deciphering the Mechanisms behind Brain Aging. | Chao CC et al. | β | 2021 | β |
| Human Keratinocytes Adopt Neuronal Fates After <i>In Utero</i> Transplantation in the Developing Rat Brain. | Tenorio-Mina A et al. | β | 2021 | β |
| Human pluripotent stem cell-derived lung organoids: Potential applications in development and disease modeling. | Tian L et al. | β | 2021 | β |
| Human stem cell models to study host-virus interactions in the central nervous system. | Harschnitz O et al. | β | 2021 | β |
| Identification of ASCL1 as a determinant for human iPSC-derived dopaminergic neurons. | Earley AM et al. | β | 2021 | β |
| Isolation and Neuronal Reprogramming of Mouse Embryonic Fibroblasts. | Adrian-Segarra JM et al. | β | 2021 | β |
| Live Imaging of Primary Neurons in Long-Term Cryopreserved Human Nerve Tissue. | Fortea M et al. | β | 2021 | β |
| Long-term culture of SH-SY5Y neuroblastoma cells in the absence of neurotrophins: A novel model of neuronal ageing. | Strother L et al. | β | 2021 | β |
| Molecular and Functional Links between Neurodevelopmental Processes and Treatment-Induced Neuroendocrine Plasticity in Prostate Cancer Progression. | KaarijΓ€rvi R et al. | β | 2021 | β |
| NeuroD1 promotes tumor cell proliferation and tumorigenesis by directly activating the pentose phosphate pathway in colorectal carcinoma. | Li Z et al. | β | 2021 | β |
| New Insights Into the Intricacies of Proneural Gene Regulation in the Embryonic and Adult Cerebral Cortex. | Oproescu AM et al. | β | 2021 | β |
| [Pharmacological studies using iPSC-derived neurons from patients with schizophrenia]. | Nakazawa T | β | 2021 | β |
| Reprogramming Human Adult Fibroblasts into GABAergic Interneurons. | Bruzelius A et al. | β | 2021 | β |
| Role of miR-211 in a PC12 cell model of Alzheimer's disease via regulation of neurogenin 2. | Liu XH et al. | β | 2021 | β |
| Screening Platforms for Genetic Epilepsies-Zebrafish, iPSC-Derived Neurons, and Organoids. | Shcheglovitov A et al. | β | 2021 | β |
| Stem cell-derived neurons reflect features of protein networks, neuropathology, and cognitive outcome of their aged human donors. | Lagomarsino VN et al. | β | 2021 | β |
| The application of in vitro-derived human neurons in neurodegenerative disease modeling. | D'Souza GX et al. | β | 2021 | β |
| Transcriptional Profiling During Neural Conversion. | Afeworki Y et al. | β | 2021 | β |
| Transcription Factor Reprogramming in the Inner Ear: Turning on Cell Fate Switches to Regenerate Sensory Hair Cells. | Iyer AA et al. | β | 2021 | β |
| Transfer to the clinic: refining forward programming of hPSCs to megakaryocytes for platelet production in bioreactors. | Evans AL et al. | β | 2021 | β |
| A decade of questions about the fluidity of cell identity. | Masserdotti G et al. | β | 2020 | β |
| Advances in Human Stem Cells and Genome Editing to Understand and Develop Treatment for Fragile X Syndrome. | Zhao X et al. | β | 2020 | β |
| Advances in mt-tRNA Mutation-Caused Mitochondrial Disease Modeling: Patients' Brain in a Dish. | Povea-Cabello S et al. | β | 2020 | β |
| Aggregation of mutant cysteine string protein-Ξ± via Fe-S cluster binding is mitigated by iron chelators. | Naseri NN et al. | β | 2020 | β |
| A NeuroD1 AAV-Based Gene Therapy for Functional Brain Repair after Ischemic Injury through InΒ Vivo Astrocyte-to-Neuron Conversion. | Chen YC et al. | β | 2020 | β |
| Cell Reprogramming Preserving Epigenetic Age: Advantages and Limitations. | Samoylova EM et al. | β | 2020 | β |
| Conversion of human urine-derived cells into neuron-like cells by small molecules. | Liu D et al. | β | 2020 | β |
| Development and Differentiation of Midbrain Dopaminergic Neuron: From Bench to Bedside. | Wang M et al. | β | 2020 | β |
| Development of a 3-D Organoid System Using Human Induced Pluripotent Stem Cells to Model Idiopathic Autism. | Lunden JW et al. | β | 2020 | β |
| Differential sensitivity of human neurons carrying ΞΌ opioid receptor (MOR) N40D variants in response to ethanol. | Scarnati MS et al. | β | 2020 | β |
| Direct cell-fate conversion of somatic cells: Toward regenerative medicine and industries. | Horisawa K et al. | β | 2020 | β |
| Direct conversion of human fibroblasts into therapeutically active vascular wall-typical mesenchymal stem cells. | Steens J et al. | β | 2020 | β |
| Direct Conversion of Human Stem Cell-Derived Glial Progenitor Cells into GABAergic Interneurons. | Giacomoni J et al. | β | 2020 | β |
| Direct Neuronal Reprogramming of Common Marmoset Fibroblasts by ASCL1, microRNA-9/9*, and microRNA-124 Overexpression. | Nemoto A et al. | β | 2020 | β |
| From in vitro to in vivo reprogramming for neural transdifferentiation: An approach for CNS tissue remodeling using stem cell technology. | Egawa N et al. | β | 2020 | β |
| Gap Junction Dependent Cell Communication Is Modulated During Transdifferentiation of Mesenchymal Stem/Stromal Cells Towards Neuron-Like Cells. | Dilger N et al. | β | 2020 | β |
| Generation of self-organized sensory ganglion organoids and retinal ganglion cells from fibroblasts. | Xiao D et al. | β | 2020 | β |
| How to reprogram human fibroblasts to neurons. | Xu Z et al. | β | 2020 | β |
| Human Induced Pluripotent Stem Cells Derived from a Cardiac Somatic Source: Insights for an In-Vitro Cardiomyocyte Platform. | Lodrini AM et al. | β | 2020 | β |
| Human in vitro models for understanding mechanisms of autism spectrum disorder. | Gordon A et al. | β | 2020 | β |
| Human pluripotent stem cell-derived models and drug screening in CNS precision medicine. | Silva MC et al. | β | 2020 | β |
| Human Pluripotent Stem Cell-Derived Neural Cells as a Relevant Platform for Drug Screening in Alzheimer's Disease. | Garcia-Leon JA et al. | β | 2020 | β |
| Human transcription factors responsive to initial reprogramming predominantly undergo legitimate reprogramming during fibroblast conversion to iPSCs. | Cevallos RR et al. | β | 2020 | β |
| Integrating CRISPR Engineering and hiPSC-Derived 2D Disease Modeling Systems. | Rehbach K et al. | β | 2020 | β |
| Integration of CRISPR-engineering and hiPSC-based models of psychiatric genomics. | Matos MR et al. | β | 2020 | β |
| Investigation of Schizophrenia with Human Induced Pluripotent Stem Cells. | Powell SK et al. | β | 2020 | β |
| In Vitro and In Vivo Models for the Investigation of Potential Drugs Against Schizophrenia. | KoszΕa O et al. | β | 2020 | β |
| iPSC modeling of rare pediatric disorders. | Freel BA et al. | β | 2020 | β |
| Mass Generation, Neuron Labeling, and 3D Imaging of Minibrains. | Govindan S et al. | β | 2020 | β |
| Master Regulators and Cofactors of Human Neuronal Cell Fate Specification Identified by CRISPR Gene Activation Screens. | Black JB et al. | β | 2020 | β |
| Mechanisms of small nerve fiber pathology. | Gross F et al. | β | 2020 | β |
| miRNA-Based Rapid Differentiation of Purified Neurons from hPSCs Advancestowards Quick Screening for Neuronal Disease Phenotypes In Vitro. | Ishikawa M et al. | β | 2020 | β |
| Modeling Alzheimer's disease with iPSC-derived brain cells. | Penney J et al. | β | 2020 | β |
| Modeling Psychiatric Disorder Biology with Stem Cells. | Das D et al. | β | 2020 | β |
| Modelling multiple sclerosis using induced pluripotent stem cells. | MartΓnez-Larrosa J et al. | β | 2020 | β |
| MYT1L: A systematic review of genetic variation encompassing schizophrenia and autism. | Mansfield P et al. | β | 2020 | β |
| NEUROD1 Intrinsically Initiates Differentiation of Induced Pluripotent Stem Cells into Neural Progenitor Cells. | Choi WY et al. | β | 2020 | β |
| Neurogenic differentiation factor 1 promotes colorectal cancer cell proliferation and tumorigenesis by suppressing the p53/p21 axis. | Lei K et al. | β | 2020 | β |
| Neurogenic Niche Conversion Strategy Induces Migration and Functional Neuronal Differentiation of Neural Precursor Cells Following Brain Injury. | Wang Z et al. | β | 2020 | β |
| Neuronal Reprogramming for Tissue Repair and Neuroregeneration. | Liou RH et al. | β | 2020 | β |
| Neuroregeneration: Regulation in Neurodegenerative Diseases and Aging. | Bobkova NV et al. | β | 2020 | β |
| Norrin mediates tumor-promoting and -suppressive effects in glioblastoma via Notch and Wnt. | El-Sehemy A et al. | β | 2020 | β |
| Particles Containing Cells as a Strategy to Promote Remyelination in Patients With Multiple Sclerosis. | MatΓas-Guiu J et al. | β | 2020 | β |
| Pharmacologic fibroblast reprogramming into photoreceptors restores vision. | Mahato B et al. | β | 2020 | β |
| Practical choice for robust and efficient differentiation of human pluripotent stem cells. | Fang M et al. | β | 2020 | β |
| Precision Medicine in Rare Diseases. | VillalΓ³n-GarcΓa I et al. | β | 2020 | β |
| Probing disrupted neurodevelopment in autism using human stem cell-derived neurons and organoids: An outlook into future diagnostics and drug development. | Yang G et al. | β | 2020 | β |
| Prospects of Directly Reprogrammed Adult Human Neurons for Neurodegenerative Disease Modeling and Drug Discovery: iN vs. iPSCs Models. | Zhang Y et al. | β | 2020 | β |
| Protein-based direct reprogramming of fibroblasts to neuronal cells using 30Kc19 protein and transcription factor Ascl1. | Ryu J et al. | β | 2020 | β |
| Rapid generation of regionally specified CNS neurons by sequential patterning and conversion of human induced pluripotent stem cells. | Chen M et al. | β | 2020 | β |
| Rebuilding Tendons: A Concise Review on the Potential of Dermal Fibroblasts. | Chu J et al. | β | 2020 | β |
| Schwann Cell-Like Cells: Origin and Usability for Repair and Regeneration of the Peripheral and Central Nervous System. | Hopf A et al. | β | 2020 | β |
| Small molecular compounds efficiently convert human fibroblasts directly into neurons. | Yang J et al. | β | 2020 | β |
| SOX2 has dual functions as a regulator in the progression of neuroendocrine prostate cancer. | Li H et al. | β | 2020 | β |
| The Dynamics of Transcriptional Activation by Hepatic Reprogramming Factors. | Horisawa K et al. | β | 2020 | β |
| The iNs and Outs of Direct Reprogramming to Induced Neurons. | Carter JL et al. | β | 2020 | β |
| Towards stem cell-based neuronal regeneration for glaucoma. | Hua ZQ et al. | β | 2020 | β |
| Transcription Factor-Based Fate Specification and Forward Programming for Neural Regeneration. | Flitsch LJ et al. | β | 2020 | β |
| Transcriptomic and epigenomic dynamics associated with development of human iPSC-derived GABAergic interneurons. | Inglis GAS et al. | β | 2020 | β |
| Using induced pluripotent stem cell neuronal models to study neurodegenerative diseases. | Zhang X et al. | β | 2020 | β |
| AAV9-Mediated Cdk5 Inhibitory Peptide Reduces Hyperphosphorylated Tau and Inflammation and Ameliorates Behavioral Changes Caused by Overexpression of p25 in the Brain. | Xu M et al. | β | 2019 | β |
| Acquisition of functional neurons by direct conversion: Switching the developmental clock directly. | Chen S et al. | β | 2019 | β |
| ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? | Mejzini R et al. | β | 2019 | β |
| Alternative 3' UTRs direct localization of functionally diverse protein isoforms in neuronal compartments. | Ciolli Mattioli C et al. | β | 2019 | β |
| A Revolution in Reprogramming: Small Molecules. | Zhou J et al. | β | 2019 | β |
| Attenuation of PRRX2 and HEY2 enables efficient conversion of adult human skin fibroblasts to neurons. | Li H et al. | β | 2019 | β |
| bHLH transcription factors in neural development, disease, and reprogramming. | Dennis DJ et al. | β | 2019 | β |
| Brain Organoids as Tools for Modeling Human Neurodevelopmental Disorders. | Adams JW et al. | β | 2019 | β |
| Cell Reprogramming: The Many Roads to Success. | Aydin B et al. | β | 2019 | β |
| Chemical modulation of transcriptionally enriched signaling pathways to optimize the conversion of fibroblasts into neurons. | Herdy J et al. | β | 2019 | β |
| Chemotherapy-Induced Neuropathy and Drug Discovery Platform Using Human Sensory Neurons Converted Directly from Adult Peripheral Blood. | Vojnits K et al. | β | 2019 | β |
| Combination of Chemical and Neurotrophin Stimulation Modulates Neurotransmitter Receptor Expression and Activity in Transdifferentiating Human Adipose Stromal Cells. | Nery AA et al. | β | 2019 | β |
| Compartmentalized Devices as Tools for Investigation of Human Brain Network Dynamics. | Fantuzzo JA et al. | β | 2019 | β |
| Computational Analysis of Altering Cell Fate. | Abdallah HM et al. | β | 2019 | β |
| Contribution of induced pluripotent stem cell technologies to the understanding of cellular phenotypes in schizophrenia. | Balan S et al. | β | 2019 | β |
| Conversion of hepatoma cells to hepatocyte-like cells by defined hepatocyte nuclear factors. | Cheng Z et al. | β | 2019 | β |
| Deconstructing age reprogramming. | Singh PB et al. | β | 2019 | β |
| Direct conversion of fibroblasts into urothelial cells that may be recruited to regenerating mucosa of injured urinary bladder. | Inoue Y et al. | β | 2019 | β |
| Direct conversion of fibroblasts to osteoblasts as a novel strategy for bone regeneration in elderly individuals. | Chang Y et al. | β | 2019 | β |
| Direct conversion of mouse embryonic fibroblast to osteoblast cells using hLMP-3 with Yamanaka factors. | Ahmed MF et al. | β | 2019 | β |
| Directed Differentiation of Pluripotent Stem Cells by Transcription Factors. | Oh Y et al. | β | 2019 | β |
| Direct Neuronal Reprogramming Reveals Unknown Functions for Known Transcription Factors. | Colasante G et al. | β | 2019 | β |
| Direct reprogramming into interneurons: potential for brain repair. | Pereira M et al. | β | 2019 | β |
| Direct Reprogramming of Human Neurons Identifies MARCKSL1 as a Pathogenic Mediator of Valproic Acid-Induced Teratogenicity. | Chanda S et al. | β | 2019 | β |
| Dual modulation of neuron-specific microRNAs and the REST complex promotes functional maturation of human adult induced neurons. | Birtele M et al. | β | 2019 | β |
| Evolving principles underlying neural lineage conversion and their relevance for biomedical translation. | Flitsch LJ et al. | β | 2019 | β |
| Examining the fundamental biology of a novel population of directly reprogrammed human neural precursor cells. | Ahlfors JE et al. | β | 2019 | β |
| Functional Cortical Axon Tracts Generated from Human Stem Cell-Derived Neurons. | Chen HI et al. | β | 2019 | β |
| Genome-wide analysis of RNA and protein localization and local translation in mESC-derived neurons. | Ludwik KA et al. | β | 2019 | β |
| Induced pluripotent stem cell-based modeling of mutant LRRK2-associated Parkinson's disease. | Weykopf B et al. | β | 2019 | β |
| Inhibition of Glioma Development by ASCL1-Mediated Direct Neuronal Reprogramming. | Cheng X et al. | β | 2019 | β |
| Intestinal Neurod1 expression impairs paneth cell differentiation and promotes enteroendocrine lineage specification. | Li HJ et al. | β | 2019 | β |
| In Vitro Functional Characterization of Human Neurons and Astrocytes Using Calcium Imaging and Electrophysiology. | Hansen MG et al. | β | 2019 | β |
| In vivo direct reprogramming of glial linage to mature neurons after cerebral ischemia. | Yamashita T et al. | β | 2019 | β |
| Lipidomic Analysis of Ξ±-Synuclein Neurotoxicity Identifies Stearoyl CoA Desaturase as a Target for Parkinson Treatment. | Fanning S et al. | β | 2019 | β |
| Making NSC and Neurons from Patient-Derived Tissue Samples. | Mukherjee O et al. | β | 2019 | β |
| Matrices, scaffolds & carriers for cell delivery in nerve regeneration. | Wang ZZ et al. | β | 2019 | β |
| Metastable Reprogramming State of Single Transcription Factor-Derived Induced Hepatocyte-Like Cells. | Hwang SI et al. | β | 2019 | β |
| Modeling Psychiatric Diseases with Induced Pluripotent Stem Cells. | van Hugte E et al. | β | 2019 | β |
| Molecular Interaction Networks to Select Factors for Cell Conversion. | Ouyang JF et al. | β | 2019 | β |
| Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons. | Marro SG et al. | β | 2019 | β |
| Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma. | Bandopadhayay P et al. | β | 2019 | β |
| Next-generation disease modeling with direct conversion: a new path to old neurons. | Traxler L et al. | β | 2019 | β |
| Novel Direct Conversion of Microglia to Neurons. | Trudler D et al. | β | 2019 | β |
| Pioneer Factor NeuroD1 Rearranges Transcriptional and Epigenetic Profiles to Execute Microglia-Neuron Conversion. | Matsuda T et al. | β | 2019 | β |
| Plasmid-based generation of neural cells from human fibroblasts using non-integrating episomal vectors. | Dai SB et al. | β | 2019 | β |
| Precision medicine in pantothenate kinase-associated neurodegeneration. | Alvarez-Cordoba M et al. | β | 2019 | β |
| Rapid and Efficient Conversion of Human Fibroblasts into Functional Neurons by Small Molecules. | Yang Y et al. | β | 2019 | β |
| Reprogramming of Keratinocytes as Donor or Target Cells Holds Great Promise for Cell Therapy and Regenerative Medicine. | Zhang Y et al. | β | 2019 | β |
| Retinal Ganglion Cell Replacement: Current Status and Challenges Ahead. | Miltner AM et al. | β | 2019 | β |
| Seeking fate-CRISPRa screens reveal new neural lineage and reprogramming factors. | Baumann V et al. | β | 2019 | β |
| Shared and derived features of cellular diversity in the human cerebral cortex. | Miller DJ et al. | β | 2019 | β |
| Single-cell multimodal transcriptomics to study neuronal diversity in human stem cell-derived brain tissue and organoid models. | van den Hurk M et al. | β | 2019 | β |
| Single-cell study of neural stem cells derived from human iPSCs reveals distinct progenitor populations with neurogenic and gliogenic potential. | Lam M et al. | β | 2019 | β |
| Small molecules enhance neurogenic differentiation of dental-derived adult stem cells. | Heng BC et al. | β | 2019 | β |
| Stem cell therapies for Alzheimer's disease: is it time? | Wang SM et al. | β | 2019 | β |
| Stemming retinal regeneration with pluripotent stem cells. | Jin ZB et al. | β | 2019 | β |
| Take the shortcut - direct conversion of somatic cells into induced neural stem cells and their biomedical applications. | Erharter A et al. | β | 2019 | β |
| The crucial role of DNA-dependent protein kinase and myelin transcription factor 1-like protein in the miR-141 tumor suppressor network. | Wang B et al. | β | 2019 | β |
| Transcription Factor-Directed Re-wiring of Chromatin Architecture for Somatic Cell Nuclear Reprogramming toward trans-Differentiation. | Dall'Agnese A et al. | β | 2019 | β |
| Transcription Factors That Govern Development and Disease: An Achilles Heel in Cancer. | Huilgol D et al. | β | 2019 | β |
| Using Dental Pulp Stem Cells for Stroke Therapy. | Gancheva MR et al. | β | 2019 | β |
| Using human stem cells as a model system to understand the neural mechanisms of alcohol use disorders: Current status and outlook. | Scarnati MS et al. | β | 2019 | β |
| A Bivalent Securinine Compound SN3-L6 Induces Neuronal Differentiation via Translational Upregulation of Neurogenic Transcription Factors. | Liao Y et al. | β | 2018 | β |
| Aging in a Dish: iPSC-Derived and Directly Induced Neurons for Studying Brain Aging and Age-Related Neurodegenerative Diseases. | Mertens J et al. | β | 2018 | β |
| Analysis of transcriptional activity by the Myt1 and Myt1l transcription factors. | Manukyan A et al. | β | 2018 | β |
| Assessment of stem cell differentiation based on genome-wide expression profiles. | Godoy P et al. | β | 2018 | β |
| A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation. | Sheng C et al. | β | 2018 | β |
| Cellular Models: HD Patient-Derived Pluripotent Stem Cells. | Geater C et al. | β | 2018 | β |
| Chemical compound-based direct reprogramming for future clinical applications. | Takeda Y et al. | β | 2018 | β |
| Conversion of adult human fibroblasts into neural precursor cells using chemically modified mRNA. | Connor B et al. | β | 2018 | β |
| Direct Conversion of Somatic Cells into Induced Neurons. | An N et al. | β | 2018 | β |
| Directing neuronal cell fate in vitro: Achievements and challenges. | Riemens RJM et al. | β | 2018 | β |
| Direct Reprogramming of Adult Human Somatic Stem Cells Into Functional Neurons Using <i>Sox2, Ascl1</i>, and <i>Neurog2</i>. | AraΓΊjo JAM et al. | β | 2018 | β |
| Direct Reprogramming of Spiral Ganglion Non-neuronal Cells into Neurons: Toward Ameliorating Sensorineural Hearing Loss by Gene Therapy. | Noda T et al. | β | 2018 | β |
| Diverse reprogramming codes for neuronal identity. | Tsunemoto R et al. | β | 2018 | β |
| Diversity among POU transcription factors in chromatin recognition and cell fate reprogramming. | Malik V et al. | β | 2018 | β |
| Dynamic Changes of the Mitochondria in Psychiatric Illnesses: New Mechanistic Insights From Human Neuronal Models. | Srivastava R et al. | β | 2018 | β |
| Effects of 3D culturing conditions on the transcriptomic profile of stem-cell-derived neurons. | Tekin H et al. | β | 2018 | β |
| Establishment and Identification of a CiPSC Lineage Reprogrammed from FSP-tdTomato Mouse Embryonic Fibroblasts (MEFs). | Chen R et al. | β | 2018 | β |
| Generation of dopamine neuronal-like cells from induced neural precursors derived from adult human cells by non-viral expression of lineage factors. | Playne R et al. | β | 2018 | β |
| Generation of Human Neural Stem Cells by Direct Phenotypic Conversion. | Kwon D et al. | β | 2018 | β |
| Genetics of Alcohol Use Disorder: A Role for Induced Pluripotent Stem Cells? | Prytkova I et al. | β | 2018 | β |
| High-throughput drug screens for amyotrophic lateral sclerosis drug discovery. | McGown A et al. | β | 2018 | β |
| hsa-let-7c miRNA Regulates Synaptic and Neuronal Function in Human Neurons. | McGowan H et al. | β | 2018 | β |
| Human Cortical Neuron Generation Using Cell Reprogramming: A Review of Recent Advances. | McCaughey-Chapman A et al. | β | 2018 | β |
| Human Spinal Oligodendrogenic Neural Progenitor Cells Promote Functional Recovery After Spinal Cord Injury by Axonal Remyelination and Tissue Sparing. | Nagoshi N et al. | β | 2018 | β |
| Human stem cell modeling in neurofibromatosis type 1 (NF1). | Wegscheid ML et al. | β | 2018 | β |
| Induced pluripotent stem cells (iPSCs) as model to study inherited defects of neurotransmission in inborn errors of metabolism. | Jung-Klawitter S et al. | β | 2018 | β |
| Interplay of cell-cell contacts and RhoA/MRTF-A signaling regulates cardiomyocyte identity. | Dorn T et al. | β | 2018 | β |
| Low-input and multiplexed microfluidic assay reveals epigenomic variation across cerebellum and prefrontal cortex. | Ma S et al. | β | 2018 | β |
| Mapping Cellular Reprogramming via Pooled Overexpression Screens with Paired Fitness and Single-Cell RNA-Sequencing Readout. | Parekh U et al. | β | 2018 | β |
| Materials for Neural Differentiation, Trans-Differentiation, and Modeling of Neurological Disease. | Gong L et al. | β | 2018 | β |
| Mechanisms of Cortical Differentiation. | Adnani L et al. | β | 2018 | β |
| Mechanisms of dietary flavonoid action in neuronal function and neuroinflammation. | Jaeger BN et al. | β | 2018 | β |
| MicroRNA-Directed Neuronal Reprogramming as a Therapeutic Strategy for Neurological Diseases. | Faravelli I et al. | β | 2018 | β |
| Modeling Neuropsychiatric and Neurodegenerative Diseases With Induced Pluripotent Stem Cells. | LaMarca EA et al. | β | 2018 | β |
| Myt1 and Myt1l transcription factors limit proliferation in GBM cells by repressing YAP1 expression. | Melhuish TA et al. | β | 2018 | β |
| Myt1l induced direct reprogramming of pericytes into cholinergic neurons. | Liang XG et al. | β | 2018 | β |
| Myt1L Promotes Differentiation of Oligodendrocyte Precursor Cells and is Necessary for Remyelination After Lysolecithin-Induced Demyelination. | Shi Y et al. | β | 2018 | β |
| Neural stem cell differentiation into mature neurons: Mechanisms of regulation and biotechnological applications. | Vieira MS et al. | β | 2018 | β |
| Neural stem cell therapy aiming at better functional recovery after spinal cord injury. | Zhu Y et al. | β | 2018 | β |
| New approaches for brain repair-from rescue to reprogramming. | Barker RA et al. | β | 2018 | β |
| Nonintegrating Direct Conversion Using mRNA into Hepatocyte-Like Cells. | Yoon S et al. | β | 2018 | β |
| NTF3 Is a Novel Target Gene of the Transcription Factor POU3F2 and Is Required for Neuronal Differentiation. | Lin YJ et al. | β | 2018 | β |
| Parkinson's disease: what the model systems have taught us so far. | Ghatak S et al. | β | 2018 | β |
| Patient-Derived Induced Pluripotent Stem Cells and Organoids for Modeling Alpha Synuclein Propagation in Parkinson's Disease. | Koh YH et al. | β | 2018 | β |
| Patient-Derived iPSCs and iNs-Shedding New Light on the Cellular Etiology of Neurodegenerative Diseases. | Tang BL | β | 2018 | β |
| Potentials of Cellular Reprogramming as a Novel Strategy for Neuroregeneration. | Fang L et al. | β | 2018 | β |
| POU3F2 participates in cognitive function and adult hippocampal neurogenesis via mammalian-characteristic amino acid repeats. | Hashizume K et al. | β | 2018 | β |
| Prolonged inhibition of hepatocellular carcinoma cell proliferation by combinatorial expression of defined transcription factors. | Takashima Y et al. | β | 2018 | β |
| Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells (NPCs). | Williams M et al. | β | 2018 | β |
| Recent Advances: Decoding Alzheimer's Disease With Stem Cells. | Fang Y et al. | β | 2018 | β |
| Recent Advances in the Genetics of Schizophrenia. | Avramopoulos D | β | 2018 | β |
| Representing Diversity in the Dish: Using Patient-Derived <i>in Vitro</i> Models to Recreate the Heterogeneity of Neurological Disease. | Ghaffari LT et al. | β | 2018 | β |
| Reprogramming Glia Into Neurons in the Peripheral Auditory System as a Solution for Sensorineural Hearing Loss: Lessons From the Central Nervous System. | Meas SJ et al. | β | 2018 | β |
| Reprogramming glioblastoma multiforme cells into neurons by protein kinase inhibitors. | Yuan J et al. | β | 2018 | β |
| Reprogramming of mouse fibroblasts into neural lineage cells using biomaterials. | Kantawong F et al. | β | 2018 | β |
| Shaping Gene Expression by Landscaping Chromatin Architecture: Lessons from a Master. | Sartorelli V et al. | β | 2018 | β |
| Single-cell genomics to guide human stem cell and tissue engineering. | Camp JG et al. | β | 2018 | β |
| Stem cell- and gene-based therapies as potential candidates in Alzheimer's therapy. | Hosseini SA et al. | β | 2018 | β |
| Stem cells for spinal cord injuries bearing translational potential. | Dalamagkas K et al. | β | 2018 | β |
| Targeting Alzheimer's disease with gene and cell therapies. | Loera-Valencia R et al. | β | 2018 | β |
| The fragile X mutation impairs homeostatic plasticity in human neurons by blocking synaptic retinoic acid signaling. | Zhang Z et al. | β | 2018 | β |
| The PNKD gene is associated with Tourette Disorder or Tic disorder in a multiplex family. | Sun N et al. | β | 2018 | β |
| Therapeutic approaches for cardiac regeneration and repair. | Hashimoto H et al. | β | 2018 | β |
| The transcription factor POU3F2 regulates a gene coexpression network in brain tissue from patients with psychiatric disorders. | Chen C et al. | β | 2018 | β |
| Three-dimensional brain-like microenvironments facilitate the direct reprogramming of fibroblasts into therapeutic neurons. | Jin Y et al. | β | 2018 | β |
| Transcription factor induced conversion of human fibroblasts towards the hair cell lineage. | Duran Alonso MB et al. | β | 2018 | β |
| Transcription factor programming of human ES cells generates functional neurons expressing both upper and deep layer cortical markers. | Miskinyte G et al. | β | 2018 | β |
| Transdifferentiation: a new promise for neurodegenerative diseases. | Mollinari C et al. | β | 2018 | β |
| Transdifferentiation of human adult peripheral blood T cells into neurons. | Tanabe K et al. | β | 2018 | β |
| Unsupervised clustering and epigenetic classification of single cells. | Zamanighomi M et al. | β | 2018 | β |
| A computational systems approach identifies synergistic specification genes that facilitate lineage conversion to prostate tissue. | Talos F et al. | β | 2017 | β |
| Advanced Gene Manipulation Methods for Stem Cell Theranostics. | Rathnam C et al. | β | 2017 | β |
| Alzheimer's disease, dementia, and stem cell therapy. | Duncan T et al. | β | 2017 | β |
| An update on stem cell biology and engineering for brain development. | Parr CJC et al. | β | 2017 | β |
| Application of CRISPR/Cas9 to the study of brain development and neuropsychiatric disease. | Powell SK et al. | β | 2017 | β |
| ASCL1 Reorganizes Chromatin to Direct Neuronal Fate and Suppress Tumorigenicity of Glioblastoma Stem Cells. | Park NI et al. | β | 2017 | β |
| Associations of the Intellectual Disability Gene MYT1L with Helix-Loop-Helix Gene Expression, Hippocampus Volume and Hippocampus Activation During Memory Retrieval. | Kepa A et al. | β | 2017 | β |
| Beyond proneural: emerging functions and regulations of proneural proteins. | Guillemot F et al. | β | 2017 | β |
| Biophysical regulation of cell reprogramming. | Wong SY et al. | β | 2017 | β |
| BRaf signaling principles unveiled by large-scale human mutation analysis with a rapid lentivirus-based gene replacement method. | Lim CS et al. | β | 2017 | β |
| Brain imaging genetics in ADHD and beyond - Mapping pathways from gene to disorder at different levels of complexity. | Klein M et al. | β | 2017 | β |
| Brain repair from intrinsic cell sources: Turning reactive glia into neurons. | Torper O et al. | β | 2017 | β |
| CAGE: Chromatin Analogous Gene Expression. | Zadegan RM et al. | β | 2017 | β |
| Cell fate modification toward the hepatic lineage by extrinsic factors. | Kawamata M et al. | β | 2017 | β |
| Cell reprogramming: Therapeutic potential and the promise of rejuvenation for the aging brain. | LΓ³pez-LeΓ³n M et al. | β | 2017 | β |
| Changing POU dimerization preferences converts Oct6 into a pluripotency inducer. | Jerabek S et al. | β | 2017 | β |
| Chemical reprogramming of mouse embryonic and adult fibroblast into endoderm lineage. | Cao S et al. | β | 2017 | β |
| Chronic Ξ²-Cell Depolarization Impairs Ξ²-Cell Identity by Disrupting a Network of Ca<sup>2+</sup>-Regulated Genes. | Stancill JS et al. | β | 2017 | β |
| Cochlear hair cell regeneration after noise-induced hearing loss: Does regeneration follow development? | Zheng F et al. | β | 2017 | β |
| Constitutively Active SMAD2/3 Are Broad-Scope Potentiators of Transcription-Factor-Mediated Cellular Reprogramming. | Ruetz T et al. | β | 2017 | β |
| Conversion of Goat Fibroblasts into Lineage-Specific Cells Using a Direct Reprogramming Strategy. | Guo Y et al. | β | 2017 | β |
| Coordinated generation of multiple ocular-like cell lineages and fabrication of functional corneal epithelial cell sheets from human iPS cells. | Hayashi R et al. | β | 2017 | β |
| Copy number variation in a hospital-based cohort of children with epilepsy. | Vlaskamp DRM et al. | β | 2017 | β |
| CRISPR Transcriptional Activation Analysis Unmasks an Occult Ξ³-Secretase Processivity Defect in Familial Alzheimer's Disease Skin Fibroblasts. | Inoue K et al. | β | 2017 | β |
| Cyclin-Dependent Kinase-Dependent Phosphorylation of Sox2 at Serine 39 Regulates Neurogenesis. | Lim S et al. | β | 2017 | β |
| Differentiation of Human Pluripotent Stem Cells into Mesodermal and Ectodermal Derivatives Is Independent of the Type of Isogenic Reprogrammed Somatic Cells. | Philonenko ES et al. | β | 2017 | β |
| Direct Cardiac Reprogramming as a Novel Therapeutic Strategy for Treatment of Myocardial Infarction. | Ma H et al. | β | 2017 | β |
| Direct Conversion of Human Fibroblasts into Schwann Cells that Facilitate Regeneration of Injured Peripheral Nerve In Vivo. | Sowa Y et al. | β | 2017 | β |
| Direct conversion of human fibroblasts to functional excitatory cortical neurons integrating into human neural networks. | Miskinyte G et al. | β | 2017 | β |
| Direct induction of functional neuronal cells from fibroblast-like cells derived from adult human retina. | Hao L et al. | β | 2017 | β |
| Direct Neuronal Reprogramming: Achievements, Hurdles, and New Roads to Success. | GascΓ³n S et al. | β | 2017 | β |
| Direct Reprogramming of Mouse Fibroblasts toward Leydig-like Cells by Defined Factors. | Yang Y et al. | β | 2017 | β |
| Direct Reprogramming Rather than iPSC-Based Reprogramming Maintains Aging Hallmarks in Human Motor Neurons. | Tang Y et al. | β | 2017 | β |
| Disrupted neuronal maturation in Angelman syndrome-derived induced pluripotent stem cells. | Fink JJ et al. | β | 2017 | β |
| Electrophysiological properties of neurons derived from human stem cells and iNeurons inΒ vitro. | Halliwell RF | β | 2017 | β |
| Engineering cell identity: establishing new gene regulatory and chromatin landscapes. | Guo C et al. | β | 2017 | β |
| Functional Maturation of Human Stem Cell-Derived Neurons in Long-Term Cultures. | Lam RS et al. | β | 2017 | β |
| Gene Delivery Approaches for Mesenchymal Stem Cell Therapy: Strategies to Increase Efficiency and Specificity. | Oggu GS et al. | β | 2017 | β |
| Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels. | Hupe M et al. | β | 2017 | β |
| Generation of Integration-Free Induced Neurons Using Graphene Oxide-Polyethylenimine. | Baek S et al. | β | 2017 | β |
| Generation of patient specific human neural stem cells from Niemann-Pick disease type C patient-derived fibroblasts. | Sung EA et al. | β | 2017 | β |
| Generation of pure GABAergic neurons by transcription factor programming. | Yang N et al. | β | 2017 | β |
| Glia-specific enhancers and chromatin structure regulate NFIA expression and glioma tumorigenesis. | Glasgow SM et al. | β | 2017 | β |
| Human Induced Pluripotent Cell-Derived Sensory Neurons for Fate Commitment of Bone Marrow-Derived Schwann Cells: Implications for Remyelination Therapy. | Cai S et al. | β | 2017 | β |
| Human pluripotent stem cells in modeling human disorders: the case of fragile X syndrome. | Vershkov D et al. | β | 2017 | β |
| Identification of transcription factors that promote the differentiation of human pluripotent stem cells into lacrimal gland epithelium-like cells. | Hirayama M et al. | β | 2017 | β |
| Induced dopaminergic neurons: A new promise for Parkinson's disease. | Xu Z et al. | β | 2017 | β |
| Induced neural stem cells as a means of treatment in Huntington's disease. | Choi KA et al. | β | 2017 | β |
| Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson's disease model. | Rivetti di Val Cervo P et al. | β | 2017 | β |
| KDM3A-mediated demethylation of histone H3 lysine 9 facilitates the chromatin binding of Neurog2 during neurogenesis. | Lin H et al. | β | 2017 | β |
| Lineage Reprogramming of Astroglial Cells from Different Origins into Distinct Neuronal Subtypes. | Chouchane M et al. | β | 2017 | β |
| Mesenchymal-like stem cells in canine ovary show high differentiation potential. | Trindade AB et al. | β | 2017 | β |
| MicroRNA-Mediated Reprogramming of Somatic Cells into Neural Stem Cells or Neurons. | Yang H et al. | β | 2017 | β |
| MicroRNAs Induce a Permissive Chromatin Environment that Enables Neuronal Subtype-Specific Reprogramming of Adult Human Fibroblasts. | Abernathy DG et al. | β | 2017 | β |
| Modeling HuntingtonΧ³s disease with patient-derived neurons. | Mattis VB et al. | β | 2017 | β |
| Modeling Niemann Pick type C1 using human embryonic and induced pluripotent stem cells. | OrdoΓ±ez MP et al. | β | 2017 | β |
| Modeling the phenotype of spinal muscular atrophy by the direct conversion of human fibroblasts to motor neurons. | Zhang QJ et al. | β | 2017 | β |
| NEUROG1 Regulates CDK2 to Promote Proliferation in Otic Progenitors. | Song Z et al. | β | 2017 | β |
| Neuronal replacement therapy: previous achievements and challenges ahead. | Grade S et al. | β | 2017 | β |
| New approaches for direct conversion of patient fibroblasts into neural cells. | Gopalakrishnan S et al. | β | 2017 | β |
| Partial Reprogramming of Pluripotent Stem Cell-Derived Cardiomyocytes into Neurons. | Chuang W et al. | β | 2017 | β |
| Progress towards human primordial germ cell specification in vitro. | Canovas S et al. | β | 2017 | β |
| Rapid Chromatin Switch in the Direct Reprogramming of Fibroblasts to Neurons. | Wapinski OL et al. | β | 2017 | β |
| Regulation of cAMP and GSK3 signaling pathways contributes to the neuronal conversion of glioma. | Oh J et al. | β | 2017 | β |
| Replicable Expansion and Differentiation of Neural Precursors from Adult Canine Skin. | Duncan T et al. | β | 2017 | β |
| Reprogramming cell fates by small molecules. | Ma X et al. | β | 2017 | β |
| Reprogramming of Dermal Fibroblasts into Osteo-Chondrogenic Cells with Elevated Osteogenic Potency by Defined Transcription Factors. | Wang Y et al. | β | 2017 | β |
| Reprogramming of somatic cells: iPS and iN cells. | Broccoli V | β | 2017 | β |
| Research on human glioma stem cells in China. | Zhao YD et al. | β | 2017 | β |
| REST suppression mediates neural conversion of adult human fibroblasts via microRNA-dependent and -independent pathways. | Drouin-Ouellet J et al. | β | 2017 | β |
| Scalable Production of iPSC-Derived Human Neurons to Identify Tau-Lowering Compounds by High-Content Screening. | Wang C et al. | β | 2017 | β |
| Sensitive and long-term monitoring of intracellular microRNAs using a non-integrating cytoplasmic RNA vector. | Sano M et al. | β | 2017 | β |
| Simple Maturation of Direct-Converted Hepatocytes Derived from Fibroblasts. | Cho YD et al. | β | 2017 | β |
| Single-cell gene expression analysis reveals regulators of distinct cell subpopulations among developing human neurons. | Wang J et al. | β | 2017 | β |
| Stem cell transplantation for spinal cord injury repair. | Lu P | β | 2017 | β |
| Temporal establishment of neural cell identity in vivo and in vitro. | Yuen SM et al. | β | 2017 | β |
| The essentiality of non-coding RNAs in cell reprogramming. | LuginbΓΌhl J et al. | β | 2017 | β |
| The expanding horizon of MicroRNAs in cellular reprogramming. | Adlakha YK et al. | β | 2017 | β |
| The Importance of Non-neuronal Cell Types in hiPSC-Based Disease Modeling and Drug Screening. | Gonzalez DM et al. | β | 2017 | β |
| The novel tool of cell reprogramming for applications in molecular medicine. | Mall M et al. | β | 2017 | β |
| The Potential of Targeting Brain Pathology with Ascl1/Mash1. | Tang BL | β | 2017 | β |
| The therapeutic potential of cell identity reprogramming for the treatment of aging-related neurodegenerative disorders. | Smith DK et al. | β | 2017 | β |
| The zinc finger E-box-binding homeobox 1 (<i>Zeb1</i>) promotes the conversion of mouse fibroblasts into functional neurons. | Yan L et al. | β | 2017 | β |
| Two factor-based reprogramming of rodent and human fibroblasts into Schwann cells. | Mazzara PG et al. | β | 2017 | β |
| Understanding neurodevelopmental disorders using human pluripotent stem cell-derived neurons. | Tamburini C et al. | β | 2017 | β |
| Understanding Parkinson's Disease through the Use of Cell Reprogramming. | Playne R et al. | β | 2017 | β |
| Whole-brain 3D mapping of human neural transplant innervation. | Doerr J et al. | β | 2017 | β |
| ΞΌNeurocircuitry: Establishing <i>in vitro</i> models of neurocircuits with human neurons. | Fantuzzo JA et al. | β | 2017 | β |
| 10th anniversary of iPS cells: the challenges that lie ahead. | Aoi T | β | 2016 | β |
| A Dishful of a Troubled Mind: Induced Pluripotent Stem Cells in Psychiatric Research. | KΓ‘lmΓ‘n S et al. | β | 2016 | β |
| A review of induced pluripotent stem cell, direct conversion by trans-differentiation, direct reprogramming and oligodendrocyte differentiation. | Prasad A et al. | β | 2016 | β |
| Ascl1 represses the mesendoderm induction in Xenopus. | Min Z et al. | β | 2016 | β |
| Autism-associated SHANK3 haploinsufficiency causes Ih channelopathy in human neurons. | Yi F et al. | β | 2016 | β |
| Bioinformatic and Genomic Analyses of Cellular Reprogramming and Direct Lineage Conversion. | Kareta MS | β | 2016 | β |
| Cellular Taxonomy of the Mouse Striatum as Revealed by Single-Cell RNA-Seq. | Gokce O et al. | β | 2016 | β |
| Conversion of embryonic stem cells into extraembryonic lineages by CRISPR-mediated activators. | Wei S et al. | β | 2016 | β |
| Conversion of Fibroblasts to Parvalbumin Neurons by One Transcription Factor, Ascl1, and the Chemical Compound Forskolin. | Shi Z et al. | β | 2016 | β |
| Development of regional specificity of spinal and medullary dorsal horn neurons. | Xie YF et al. | β | 2016 | β |
| Direct cell fate conversion of human somatic stem cells into cone and rod photoreceptor-like cells by inhibition of microRNA-203. | Choi SW et al. | β | 2016 | β |
| Direct conversion of human fibroblasts to induced serotonergic neurons. | Xu Z et al. | β | 2016 | β |
| Direct conversion of mouse embryonic fibroblasts into functional keratinocytes through transient expression of pluripotency-related genes. | Iacovides D et al. | β | 2016 | β |
| Direct Induction and Functional Maturation of Forebrain GABAergic Neurons from Human Pluripotent Stem Cells. | Sun AX et al. | β | 2016 | β |
| Direct Lineage Reprogramming Reveals Disease-Specific Phenotypes of Motor Neurons from Human ALS Patients. | Liu ML et al. | β | 2016 | β |
| Direct lineage reprogramming via pioneer factors; a detour through developmental gene regulatory networks. | Morris SA | β | 2016 | β |
| Direct neuronal reprogramming: learning from and for development. | Masserdotti G et al. | β | 2016 | β |
| Direct reprogramming and biomaterials for controlling cell fate. | Kim E et al. | β | 2016 | β |
| Direct reprogramming of somatic cells into neural stem cells or neurons for neurological disorders. | Hou S et al. | β | 2016 | β |
| Disease signatures for schizophrenia and bipolar disorder using patient-derived induced pluripotent stem cells. | Watmuff B et al. | β | 2016 | β |
| Engineering personalized neural tissue using functionalized transcription factors. | Willerth SM | β | 2016 | β |
| Erase and Rewind: Epigenetic Conversion of Cell Fate. | Pennarossa G et al. | β | 2016 | β |
| Ethanol-mediated activation of the NLRP3 inflammasome in iPS cells and iPS cells-derived neural progenitor cells. | De Filippis L et al. | β | 2016 | β |
| Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience. | Mertens J et al. | β | 2016 | β |
| Expandable and Rapidly Differentiating Human Induced Neural Stem Cell Lines for Multiple Tissue Engineering Applications. | Cairns DM et al. | β | 2016 | β |
| Exploiting the potential of next-generation sequencing in genomic medicine. | Pinto AM et al. | β | 2016 | β |
| Functional Comparison of Neuronal Cells Differentiated from Human Induced Pluripotent Stem Cell-Derived Neural Stem Cells under Different Oxygen and Medium Conditions. | Yamazaki K et al. | β | 2016 | β |
| Functional hyaluronate collagen scaffolds induce NSCs differentiation into functional neurons in repairing the traumatic brain injury. | Duan H et al. | β | 2016 | β |
| Generating human serotonergic neurons in vitro: Methodological advances. | Vadodaria KC et al. | β | 2016 | β |
| Generation and transplantation of reprogrammed human neurons in the brain using 3D microtopographic scaffolds. | Carlson AL et al. | β | 2016 | β |
| Generation of Directly Converted Human Osteoblasts That Are Free of Exogenous Gene and Xenogenic Protein. | Yamamoto K et al. | β | 2016 | β |
| Generation of diverse neural cell types through direct conversion. | Petersen GF et al. | β | 2016 | β |
| Generation of functional human serotonergic neurons from fibroblasts. | Vadodaria KC et al. | β | 2016 | β |
| Generation of Integration-free Induced Neural Stem Cells from Mouse Fibroblasts. | Kim SM et al. | β | 2016 | β |
| Glial progenitor cell-based treatment of the childhood leukodystrophies. | Osorio MJ et al. | β | 2016 | β |
| History of Neural Stem Cell Research and Its Clinical Application. | Takagi Y | β | 2016 | β |
| Human dermal fibroblasts in psychiatry research. | KΓ‘lmΓ‘n S et al. | β | 2016 | β |
| Human Inducible Pluripotent Stem Cells and Autism Spectrum Disorder: Emerging Technologies. | Nestor MW et al. | β | 2016 | β |
| Increased nicotine response in iPSC-derived human neurons carrying the CHRNA5 N398 allele. | Oni EN et al. | β | 2016 | β |
| Induced Pluripotent Stem Cells as a Novel Tool in Psychiatric Research. | Kim S et al. | β | 2016 | β |
| Induced Pluripotent Stem Cells: Generation Strategy and Epigenetic Mystery behind Reprogramming. | Ji P et al. | β | 2016 | β |
| Initiating Differentiation in Immortalized Multipotent Otic Progenitor Cells. | Azadeh J et al. | β | 2016 | β |
| Migration of bone marrow progenitor cells in the adult brain of rats and rabbits. | Dennie D et al. | β | 2016 | β |
| miR-124-9-9* potentiates Ascl1-induced reprogramming of cultured MΓΌller glia. | Wohl SG et al. | β | 2016 | β |
| Modeling Neurological Disease by Rapid Conversion of Human Urine Cells into Functional Neurons. | Zhang SZ et al. | β | 2016 | β |
| MyT1 Counteracts the Neural Progenitor Program to Promote Vertebrate Neurogenesis. | Vasconcelos FF et al. | β | 2016 | β |
| Nanoparticle-mediated transcriptional modification enhances neuronal differentiation of human neural stem cells following transplantation in rat brain. | Li X et al. | β | 2016 | β |
| Nanoscale bio-platforms for living cell interrogation: current status and future perspectives. | Chang L et al. | β | 2016 | β |
| Neurogenic gene regulatory pathways in the sea urchin embryo. | Wei Z et al. | β | 2016 | β |
| Neurorestoration after stroke. | Azad TD et al. | β | 2016 | β |
| PAF-Wnt signaling-induced cell plasticity is required for maintenance of breast cancer cell stemness. | Wang X et al. | β | 2016 | β |
| Pluripotent stem cell derived hepatocytes: using materials to define cellular differentiation and tissue engineering. | Lucendo-Villarin B et al. | β | 2016 | β |
| Predicting the functional states of human iPSC-derived neurons with single-cell RNA-seq and electrophysiology. | Bardy C et al. | β | 2016 | β |
| Progress and Challenges of Cell Replacement Therapy for Neurodegenerative Diseases Based on Direct Neural Reprogramming. | Chen Y et al. | β | 2016 | β |
| Rapid and efficient CRISPR/Cas9 gene inactivation in human neurons during human pluripotent stem cell differentiation and direct reprogramming. | Rubio A et al. | β | 2016 | β |
| Rapid Ngn2-induction of excitatory neurons from hiPSC-derived neural progenitor cells. | Ho SM et al. | β | 2016 | β |
| Recent Progress in Cell Reprogramming Technology for Cell Transplantation Therapy. | Yamashita T et al. | β | 2016 | β |
| Reprogramming A375 cells to inducedβresembled neuronal cells by structured overexpression of specific transcription genes. | Zhang H et al. | β | 2016 | β |
| Role of Hepatic-Specific Transcription Factors and Polycomb Repressive Complex 2 during Induction of Fibroblasts to Hepatic Fate. | Rastegar-Pouyani S et al. | β | 2016 | β |
| Role of SATB2 in human pancreatic cancer: Implications in transformation and a promising biomarker. | Yu W et al. | β | 2016 | β |
| Self-Assembling Peptide Nanofiber Scaffolds for 3-D Reprogramming and Transplantation of Human Pluripotent Stem Cell-Derived Neurons. | Francis NL et al. | β | 2016 | β |
| Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells. | Xue Y et al. | β | 2016 | β |
| Small-Molecule-Based Lineage Reprogramming Creates Functional Astrocytes. | Tian E et al. | β | 2016 | β |
| Small Molecules Facilitate Single Factor-Mediated Hepatic Reprogramming. | Lim KT et al. | β | 2016 | β |
| Small molecules increase direct neural conversion of human fibroblasts. | Pfisterer U et al. | β | 2016 | β |
| Small Molecules Modulate Chromatin Accessibility to Promote NEUROG2-Mediated Fibroblast-to-Neuron Reprogramming. | Smith DK et al. | β | 2016 | β |
| Stars from the darkest night: unlocking the neurogenic potential of astrocytes in different brain regions. | Magnusson JP et al. | β | 2016 | β |
| Stem Cell Therapy for Alzheimer's Disease: A Review of Recent Clinical Trials. | Kang JM et al. | β | 2016 | β |
| TGFΞ² signaling regulates the choice between pluripotent and neural fates during reprogramming of human urine derived cells. | Wang L et al. | β | 2016 | β |
| The Human Model: Changing Focus on Autism Research. | Muotri AR | β | 2016 | β |
| The primate-specific noncoding RNA HPAT5 regulates pluripotency during human preimplantation development and nuclear reprogramming. | Durruthy-Durruthy J et al. | β | 2016 | β |
| Transcriptomics analysis of iPSC-derived neurons and modeling of neuropsychiatric disorders. | Lin M et al. | β | 2016 | β |
| Transfer of three transcription factors via a lentiviral vector ameliorates spatial learning and memory impairment in a mouse model of Alzheimer's disease. | Chen P et al. | β | 2016 | β |
| Transplantation of human induced cerebellar granular-like cells improves motor functions in a novel mouse model of cerebellar ataxia. | Zhu T et al. | β | 2016 | β |
| Advances in reprogramming-based study of neurologic disorders. | Nityanandam A et al. | β | 2015 | β |
| AF9 promotes hESC neural differentiation through recruiting TET2 to neurodevelopmental gene loci for methylcytosine hydroxylation. | Qiao Y et al. | β | 2015 | β |
| A framework for analyzing the relationship between gene expression and morphological, topological, and dynamical patterns in neuronal networks. | de Arruda HF et al. | β | 2015 | β |
| Analysis of conditional heterozygous STXBP1 mutations in human neurons. | Patzke C et al. | β | 2015 | β |
| Ascl1 phospho-status regulates neuronal differentiation in a Xenopus developmental model of neuroblastoma. | Wylie LA et al. | β | 2015 | β |
| BIOENGINEERING. Restoring the sense of touch. | Anikeeva P et al. | β | 2015 | β |
| Chemical conversion of human fibroblasts into neuronal cells: dawn of future clinical trials. | Toyokuni S | β | 2015 | β |
| Clinical utility of neuronal cells directly converted from fibroblasts of patients for neuropsychiatric disorders: studies of lysosomal storage diseases and channelopathy. | Kano S et al. | β | 2015 | β |
| Comparative transcriptomic analysis of multiple cardiovascular fates from embryonic stem cells predicts novel regulators in human cardiogenesis. | Li Y et al. | β | 2015 | β |
| Connectivity and circuitry in a dish versus in a brain. | Chinchalongporn V et al. | β | 2015 | β |
| Construction of a functional thymic microenvironment from pluripotent stem cells for the induction of central tolerance. | Bredenkamp N et al. | β | 2015 | β |
| Convergence of advances in genomics, team science, and repositories as drivers of progress in psychiatric genomics. | Lehner T et al. | β | 2015 | β |
| Derivation of Adult Human Fibroblasts and their Direct Conversion into Expandable Neural Progenitor Cells. | Meyer S et al. | β | 2015 | β |
| Direct cardiac reprogramming: progress and challenges in basic biology and clinical applications. | Sadahiro T et al. | β | 2015 | β |
| Direct Conversion of Cord Blood CD34+ Cells Into Neural Stem Cells by OCT4. | Liao W et al. | β | 2015 | β |
| Direct Conversion of Equine Adipose-Derived Stem Cells into Induced Neuronal Cells Is Enhanced in Three-Dimensional Culture. | Petersen GF et al. | β | 2015 | β |
| Direct conversion of fibroblasts into functional astrocytes by defined transcription factors. | Caiazzo M et al. | β | 2015 | β |
| Direct conversion of human fibroblasts into functional osteoblasts by defined factors. | Yamamoto K et al. | β | 2015 | β |
| Direct Conversion of Normal and Alzheimer's Disease Human Fibroblasts into Neuronal Cells by Small Molecules. | Hu W et al. | β | 2015 | β |
| Direct Conversion Provides Old Neurons from Aged Donor's Skin. | Koch P | β | 2015 | β |
| Direct lineage reprogramming: strategies, mechanisms, and applications. | Xu J et al. | β | 2015 | β |
| Directly Reprogrammed Human Neurons Retain Aging-Associated Transcriptomic Signatures and Reveal Age-Related Nucleocytoplasmic Defects. | Mertens J et al. | β | 2015 | β |
| Direct reprogramming of induced neural progenitors: a new promising strategy for AD treatment. | Lai S et al. | β | 2015 | β |
| Direct Reprogramming-The Future of Cardiac Regeneration? | Doppler SA et al. | β | 2015 | β |
| Direct somatic lineage conversion. | Tanabe K et al. | β | 2015 | β |
| Engineered in vitro disease models. | Benam KH et al. | β | 2015 | β |
| Enhanced MyoD-induced transdifferentiation to a myogenic lineage by fusion to a potent transactivation domain. | Kabadi AM et al. | β | 2015 | β |
| Forward engineering neuronal diversity using direct reprogramming. | Tsunemoto RK et al. | β | 2015 | β |
| From "directed differentiation" to "neuronal induction": modeling neuropsychiatric disease. | Ho SM et al. | β | 2015 | β |
| Functional implications of a psychiatric risk variant within CACNA1C in induced human neurons. | Yoshimizu T et al. | β | 2015 | β |
| Generation of integration-free induced hepatocyte-like cells from mouse fibroblasts. | Kim J et al. | β | 2015 | β |
| Generation of primitive neural stem cells from human fibroblasts using a defined set of factors. | Miura T et al. | β | 2015 | β |
| How to make a midbrain dopaminergic neuron. | Arenas E et al. | β | 2015 | β |
| Human Neuropsychiatric Disease Modeling using Conditional Deletion Reveals Synaptic Transmission Defects Caused by Heterozygous Mutations in NRXN1. | Pak C et al. | β | 2015 | β |
| Induced pluripotent stem cell-derived neural stem cell therapies for spinal cord injury. | Lee-Kubli CA et al. | β | 2015 | β |
| Induced pluripotent stem cells from ALS patients for disease modeling. | Richard JP et al. | β | 2015 | β |
| Intrathecal Transplantation of Autologous Adherent Bone Marrow Cells Induces Functional Neurological Recovery in a Canine Model of Spinal Cord Injury. | Gabr H et al. | β | 2015 | β |
| Introducing directly induced microglia-like (iMG) cells from fresh human monocytes: a novel translational research tool for psychiatric disorders. | Ohgidani M et al. | β | 2015 | β |
| In Vivo Reprogramming for Brain and Spinal Cord Repair. | Chen G et al. | β | 2015 | β |
| MicroRNA-based conversion of human fibroblasts into striatal medium spiny neurons. | Richner M et al. | β | 2015 | β |
| MicroRNA-Mediated In Vitro and In Vivo Direct Conversion of Astrocytes to Neuroblasts. | Ghasemi-Kasman M et al. | β | 2015 | β |
| Modeling pain in vitro using nociceptor neurons reprogrammed from fibroblasts. | Wainger BJ et al. | β | 2015 | β |
| Moving stem cells to the clinic: potential and limitations for brain repair. | Steinbeck JA et al. | β | 2015 | β |
| Multi-site phospho-regulation of proneural transcription factors controls proliferation versus differentiation in development and reprogramming. | Philpott A | β | 2015 | β |
| Neural Zinc Finger Factor/Myelin Transcription Factor Proteins: Metal Binding, Fold, and Function. | Besold AN et al. | β | 2015 | β |
| Neurogenin 2 enhances the generation of patient-specific induced neuronal cells. | Zhao P et al. | β | 2015 | β |
| Neuronal medium that supports basic synaptic functions and activity of human neurons in vitro. | Bardy C et al. | β | 2015 | β |
| Novel Stroke Therapeutics: Unraveling Stroke Pathophysiology and Its Impact on Clinical Treatments. | George PM et al. | β | 2015 | β |
| Overcoming the hurdles for a reproducible generation of human functionally mature reprogrammed neurons. | Broccoli V et al. | β | 2015 | β |
| Potential of neural stem cell-based therapies for Alzheimer's disease. | Li XY et al. | β | 2015 | β |
| Predicting involvement of polycomb repressive complex 2 in direct conversion of mouse fibroblasts into induced neural stem cells. | Yaqubi M et al. | β | 2015 | β |
| Probing disorders of the nervous system using reprogramming approaches. | Ichida JK et al. | β | 2015 | β |
| Probing stem cell behavior using nanoparticle-based approaches. | Patel S et al. | β | 2015 | β |
| Programming and Reprogramming Cellular Age in the Era of Induced Pluripotency. | Studer L et al. | β | 2015 | β |
| RE-1 silencing transcription factor (REST): a regulator of neuronal development and neuronal/endocrine function. | Thiel G et al. | β | 2015 | β |
| Reprogrammed Functional Brown Adipocytes Ameliorate Insulin Resistance and Dyslipidemia in Diet-Induced Obesity and Type 2 Diabetes. | Kishida T et al. | β | 2015 | β |
| Reprogramming cells with synthetic proteins. | Yang X et al. | β | 2015 | β |
| Results from a horizon scan on risks associated with transplantation of human organs, tissues and cells: from donor to patient. | Herberts CA et al. | β | 2015 | β |
| Role of nanotechnology in epigenetic reprogramming. | Kadengodlu PA et al. | β | 2015 | β |
| Selective conversion of fibroblasts into peripheral sensory neurons. | Blanchard JW et al. | β | 2015 | β |
| Single Transcription Factor Conversion of Human Blood Fate to NPCs with CNS and PNS Developmental Capacity. | Lee JH et al. | β | 2015 | β |
| SOX2 and SOX2-MYC Reprogramming Process of Fibroblasts to the Neural Stem Cells Compromised by Senescence. | Winiecka-Klimek M et al. | β | 2015 | β |
| Stem cells and the evolving notion of cellular identity. | Daley GQ | β | 2015 | β |
| Stem Cells in Neurological Disorders: Emerging Therapy with Stunning Hopes. | Upadhyay G et al. | β | 2015 | β |
| Stem cell therapy: challenges ahead. | Bhagavati S | β | 2015 | β |
| The ETS Factor, ETV2: a Master Regulator for Vascular Endothelial Cell Development. | Oh SY et al. | β | 2015 | β |
| The role of microRNAs in human neural stem cells, neuronal differentiation and subtype specification. | Stappert L et al. | β | 2015 | β |
| Transcription factor-mediated reprogramming: epigenetics and therapeutic potential. | Firas J et al. | β | 2015 | β |
| Transdifferentiation of Fibroblasts by Defined Factors. | Zhao Z et al. | β | 2015 | β |
| Tumor cells undergoing direct lineage conversion to neurons: unnatural but useful? | Jiang YY et al. | β | 2015 | β |
| Understanding the molecular basis of autism in a dish using hiPSCs-derived neurons from ASD patients. | Lim CS et al. | β | 2015 | β |
| Adult-derived pluripotent stem cells. | Faulkner SD et al. | β | 2014 | β |
| A promising approach to iPSC-based cell therapy for diabetic wound treatment: direct lineage reprogramming. | Li S et al. | β | 2014 | β |
| A stochastic model dissects cell states in biological transition processes. | Armond JW et al. | β | 2014 | β |
| Autologous bone marrow-derived cell therapy combined with physical therapy induces functional improvement in chronic spinal cord injury patients. | El-Kheir WA et al. | β | 2014 | β |
| bHLH factors in self-renewal, multipotency, and fate choice of neural progenitor cells. | Imayoshi I et al. | β | 2014 | β |
| Biomineralized matrix-assisted osteogenic differentiation of human embryonic stem cells. | Kang H et al. | β | 2014 | β |
| Cell based therapies for ischemic stroke: from basic science to bedside. | Liu X et al. | β | 2014 | β |
| Change of fate commitment in adult neural progenitor cells subjected to chronic inflammation. | Covacu R et al. | β | 2014 | β |
| Concise review: Generation of neurons from somatic cells of healthy individuals and neurological patients through induced pluripotency or direct conversion. | Velasco I et al. | β | 2014 | β |
| Conversion of fibroblasts to neural cells by p53 depletion. | Zhou D et al. | β | 2014 | β |
| Crucial transcription factors in tendon development and differentiation: their potential for tendon regeneration. | Liu H et al. | β | 2014 | β |
| Dementia in a dish. | Doege CA et al. | β | 2014 | β |
| Development-inspired reprogramming of the mammalian central nervous system. | Amamoto R et al. | β | 2014 | β |
| Differentiated type II pneumocytes can be reprogrammed by ectopic Sox2 expression. | Kapere Ochieng J et al. | β | 2014 | β |
| Direct conversion of adult skin fibroblasts to endothelial cells by defined factors. | Han JK et al. | β | 2014 | β |
| Direct conversion of human fibroblasts into neuronal restricted progenitors. | Zou Q et al. | β | 2014 | β |
| Direct conversion of human fibroblasts into retinal pigment epithelium-like cells by defined factors. | Zhang K et al. | β | 2014 | β |
| Direct conversion of mouse and human fibroblasts to functional melanocytes by defined factors. | Yang R et al. | β | 2014 | β |
| Direct conversion of mouse fibroblasts into induced neural stem cells. | Kim SM et al. | β | 2014 | β |
| Directed midbrain and spinal cord neurogenesis from pluripotent stem cells to model development and disease in a dish. | Allodi I et al. | β | 2014 | β |
| Direct induction of ramified microglia-like cells from human monocytes: dynamic microglial dysfunction in Nasu-Hakola disease. | Ohgidani M et al. | β | 2014 | β |
| Direct neural conversion from human fibroblasts using self-regulating and nonintegrating viral vectors. | Lau S et al. | β | 2014 | β |
| Direct reprogrammed neuronal cells as a novel resource for cell transplantation therapy. | Yamashita T et al. | β | 2014 | β |
| Direct reprogramming of fibroblasts into myocytes to reverse fibrosis. | Muraoka N et al. | β | 2014 | β |
| Direct reprogramming of human fibroblasts to functional and expandable hepatocytes. | Huang P et al. | β | 2014 | β |
| Direct reprogramming of human fibroblasts to hepatocyte-like cells by synthetic modified mRNAs. | Simeonov KP et al. | β | 2014 | β |
| Efficient reprogramming of mouse fibroblasts to neuronal cells including dopaminergic neurons. | Oh SI et al. | β | 2014 | β |
| Electrophysiological profiles of induced neurons converted directly from adult human fibroblasts indicate incomplete neuronal conversion. | Koppensteiner P et al. | β | 2014 | β |
| Evolving toward a human-cell based and multiscale approach to drug discovery for CNS disorders. | Schadt EE et al. | β | 2014 | β |
| Exploiting pluripotent stem cell technology for drug discovery, screening, safety, and toxicology assessments. | McGivern JV et al. | β | 2014 | β |
| Fast and efficient neural conversion of human hematopoietic cells. | CastaΓ±o J et al. | β | 2014 | β |
| From skin to other cell types of the body. | Novak D et al. | β | 2014 | β |
| Generating human neurons in vitro and using them to understand neuropsychiatric disease. | PaΕca SP et al. | β | 2014 | β |
| Generation of human striatal neurons by microRNA-dependent direct conversion of fibroblasts. | Victor MB et al. | β | 2014 | β |
| Generation of induced neuronal cells by the single reprogramming factor ASCL1. | Chanda S et al. | β | 2014 | β |
| Generation of induced neurons by direct reprogramming in the mammalian cochlea. | Nishimura K et al. | β | 2014 | β |
| Generation of multipotent induced neural crest by direct reprogramming of human postnatal fibroblasts with a single transcription factor. | Kim YJ et al. | β | 2014 | β |
| Generation of patient-specific induced neuronal cells using a direct reprogramming strategy. | Wang P et al. | β | 2014 | β |
| Harnessing plasticity for the treatment of neurosurgical disorders: an overview. | Chen HI et al. | β | 2014 | β |
| Highly efficient generation of induced neurons from human fibroblasts that survive transplantation into the adult rat brain. | Pereira M et al. | β | 2014 | β |
| How to make a hippocampal dentate gyrus granule neuron. | Yu DX et al. | β | 2014 | β |
| Human adipose tissue possesses a unique population of pluripotent stem cells with nontumorigenic and low telomerase activities: potential implications in regenerative medicine. | Ogura F et al. | β | 2014 | β |
| Human pluripotent stem cell models of autism spectrum disorder: emerging frontiers, opportunities, and challenges towards neuronal networks in a dish. | Aigner S et al. | β | 2014 | β |
| Human stem cell models of neurodegeneration: a novel approach to study mechanisms of disease development. | Hargus G et al. | β | 2014 | β |
| Increased stability of microtubules in cultured olfactory neuroepithelial cells from individuals with schizophrenia. | Brown AS et al. | β | 2014 | β |
| Induced neural lineage cells as repair kits: so close, yet so far away. | Mirakhori F et al. | β | 2014 | β |
| Induced neural stem cells achieve long-term survival and functional integration in the adult mouse brain. | Hemmer K et al. | β | 2014 | β |
| Induced neuronal reprogramming. | Ang CE et al. | β | 2014 | β |
| Instant neurons: directed somatic cell reprogramming models of central nervous system disorders. | Qiang L et al. | β | 2014 | β |
| In vivo direct reprogramming of reactive glial cells into functional neurons after brain injury and in an Alzheimer's disease model. | Guo Z et al. | β | 2014 | β |
| Lineage-reprogramming of pericyte-derived cells of the adult human brain into induced neurons. | Karow M et al. | β | 2014 | β |
| Mammalian-specific sequences in pou3f2 contribute to maternal behavior. | Nasu M et al. | β | 2014 | β |
| Modeling heterogeneous patients with a clinical diagnosis of schizophrenia with induced pluripotent stem cells. | Brennand KJ et al. | β | 2014 | β |
| Molecular and cellular regulation of skeletal myogenesis. | Comai G et al. | β | 2014 | β |
| Molecular barriers to processes of genetic reprogramming and cell transformation. | Chestkov IV et al. | β | 2014 | β |
| NanoScript: a nanoparticle-based artificial transcription factor for effective gene regulation. | Patel S et al. | β | 2014 | β |
| Nervous decision-making: to divide or differentiate. | Hardwick LJ et al. | β | 2014 | β |
| Optimizing neuronal differentiation from induced pluripotent stem cells to model ASD. | Kim DS et al. | β | 2014 | β |
| Pluripotent reprogramming and lineage reprogramming: promises and challenges in cardiovascular regeneration. | He WJ et al. | β | 2014 | β |
| Potential for cell therapy in Parkinson's disease using genetically programmed human embryonic stem cell-derived neural progenitor cells. | Ambasudhan R et al. | β | 2014 | β |
| POU transcription factors in melanocytes and melanoma. | Besch R et al. | β | 2014 | β |
| Proneural bHLH genes in development and disease. | Huang C et al. | β | 2014 | β |
| Proteomic profiling of cardiac tissue by isolation of nuclei tagged in specific cell types (INTACT). | Amin NM et al. | β | 2014 | β |
| Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells. | SuvΓ ML et al. | β | 2014 | β |
| Regeneration of the damaged central nervous system through reprogramming technology: basic concepts and potential application for cell replacement therapy. | Matsui T et al. | β | 2014 | β |
| Regenerative Medicine for the Aging Brain. | Lopez-Leon M et al. | β | 2014 | β |
| Regenerative medicine in Alzheimer's disease. | Felsenstein KM et al. | β | 2014 | β |
| Remote control of induced dopaminergic neurons in parkinsonian rats. | Dell'Anno MT et al. | β | 2014 | β |
| Reprogramming cell fate: a changing story. | Chin MT | β | 2014 | β |
| Reprogramming for cardiac regeneration. | Raynaud CM et al. | β | 2014 | β |
| Reprogramming non-human primate somatic cells into functional neuronal cells by defined factors. | Zhou Z et al. | β | 2014 | β |
| Reprogramming of pig dermal fibroblast into insulin secreting cells by a brief exposure to 5-aza-cytidine. | Pennarossa G et al. | β | 2014 | β |
| Retinoic acid receptor Ξ³ (Rarg) and nuclear receptor subfamily 5, group A, member 2 (Nr5a2) promote conversion of fibroblasts to functional neurons. | Shi Z et al. | β | 2014 | β |
| Senescence impairs direct conversion of human somatic cells to neurons. | Sun CK et al. | β | 2014 | β |
| Signaling adaptor protein SH2B1 enhances neurite outgrowth and accelerates the maturation of human induced neurons. | Hsu YC et al. | β | 2014 | β |
| Small molecules enable OCT4-mediated direct reprogramming into expandable human neural stem cells. | Zhu S et al. | β | 2014 | β |
| Solving the puzzle of Parkinson's disease using induced pluripotent stem cells. | Zhao P et al. | β | 2014 | β |
| Spatiotemporal expression pattern of Myt/NZF family zinc finger transcription factors during mouse nervous system development. | Matsushita F et al. | β | 2014 | β |
| Stem cells and the treatment of Parkinson's disease. | Ali F et al. | β | 2014 | β |
| Stem cell therapy and cellular engineering for treatment of neuronal dysfunction in Huntington's disease. | Choi KA et al. | β | 2014 | β |
| The effect of substrate topography on direct reprogramming of fibroblasts to induced neurons. | Kulangara K et al. | β | 2014 | β |
| The future of cell therapies and brain repair: Parkinson's disease leads the way. | Petit GH et al. | β | 2014 | β |
| The future of neuroepigenetics in the human brain. | Mitchell A et al. | β | 2014 | β |
| The phosphorylation status of Ascl1 is a key determinant of neuronal differentiation and maturation in vivo and in vitro. | Ali FR et al. | β | 2014 | β |
| The Potential for iPS-Derived Stem Cells as a Therapeutic Strategy for Spinal Cord Injury: Opportunities and Challenges. | Khazaei M et al. | β | 2014 | β |
| The potential of alternate sources of cells for neural grafting in Parkinson's and Huntington's disease. | Drouin-Ouellet J | β | 2014 | β |
| The temporal and hierarchical control of transcription factors-induced liver to pancreas transdifferentiation. | Berneman-Zeitouni D et al. | β | 2014 | β |
| Translation: screening for novel therapeutics with disease-relevant cell types derived from human stem cell models. | Haggarty SJ et al. | β | 2014 | β |
| Treating Parkinson's disease in the 21st century: can stem cell transplantation compete? | Buttery PC et al. | β | 2014 | β |
| Tuning cell fate: from insights to vertebrate regeneration. | Kami D et al. | β | 2014 | β |
| Turning reactive glia into functional neurons in the brain. | Lu J et al. | β | 2014 | β |
| Wnts enhance neurotrophin-induced neuronal differentiation in adult bone-marrow-derived mesenchymal stem cells via canonical and noncanonical signaling pathways. | Tsai HL et al. | β | 2014 | β |
| A blueprint for engineering cell fate: current technologies to reprogram cell identity. | Morris SA et al. | β | 2013 | β |
| A cellular star atlas: using astrocytes from human pluripotent stem cells for disease studies. | Krencik R et al. | β | 2013 | β |
| Acute reduction in oxygen tension enhances the induction of neurons from human fibroblasts. | Davila J et al. | β | 2013 | β |
| Advances in cell lineage reprogramming. | Zhou J et al. | β | 2013 | β |
| A novel approach to facilitate dopaminergic neuron generation from stem-cells: the combination of genetic modification and signaling factors within a three-dimensional perfusion microbioreactor. | Song L et al. | β | 2013 | β |
| Artificial niche substrates for embryonic and induced pluripotent stem cell cultures. | Joddar B et al. | β | 2013 | β |
| A structural analysis of DNA binding by myelin transcription factor 1 double zinc fingers. | Gamsjaeger R et al. | β | 2013 | β |
| Bioengineered stem cells in neural development and neurodegeneration research. | Yuan SH et al. | β | 2013 | β |
| Biophysical regulation of epigenetic state and cell reprogramming. | Downing TL et al. | β | 2013 | β |
| Cell fate conversion: direct induction of hepatocyte-like cells from fibroblasts. | Ji S et al. | β | 2013 | β |
| Cell therapy: the final frontier for treatment of neurological diseases. | Dutta S et al. | β | 2013 | β |
| Characterization of induced neural progenitors from skin fibroblasts by a novel combination of defined factors. | Tian C et al. | β | 2013 | β |
| Chemical approaches to stem cell biology and therapeutics. | Li W et al. | β | 2013 | β |
| Concise review: chemical approaches for modulating lineage-specific stem cells and progenitors. | Xu T et al. | β | 2013 | β |
| Conversion of pericytes to neurons: a new guest at the reprogramming convention. | Nivet E et al. | β | 2013 | β |
| Creating a neural specific chromatin landscape by npBAF and nBAF complexes. | Staahl BT et al. | β | 2013 | β |
| Deconstructing mitochondrial dysfunction in Alzheimer disease. | GarcΓa-Escudero V et al. | β | 2013 | β |
| Defining the diversity of phenotypic respecification using multiple cell lines and reprogramming regimens. | Alicea B et al. | β | 2013 | β |
| Differentiation of reprogrammed human adipose mesenchymal stem cells toward neural cells with defined transcription factors. | Qu X et al. | β | 2013 | β |
| Direct cardiac reprogramming: from developmental biology to cardiac regeneration. | Qian L et al. | β | 2013 | β |
| Direct conversion of adipocyte progenitors into functional neurons. | Yang Y et al. | β | 2013 | β |
| Direct conversion of fibroblasts into neural progenitor-like cells by forced growth into 3D spheres on low attachment surfaces. | Su G et al. | β | 2013 | β |
| Direct conversion of fibroblasts to neurons by reprogramming PTB-regulated microRNA circuits. | Xue Y et al. | β | 2013 | β |
| Direct reprogramming into desired cell types by defined factors. | Ieda M | β | 2013 | β |
| Direct reprogramming of adult somatic cells into other lineages: past evidence and future perspectives. | Nizzardo M et al. | β | 2013 | β |
| Direct reprogramming of mouse fibroblasts into cardiac myocytes. | Inagawa K et al. | β | 2013 | β |
| Direct transcriptional reprogramming of adult cells to embryonic nephron progenitors. | Hendry CE et al. | β | 2013 | β |
| Environmental impact on direct neuronal reprogramming in vivo in the adult brain. | Grande A et al. | β | 2013 | β |
| Epigenetics in the human brain. | Houston I et al. | β | 2013 | β |
| Expression of Neurogenin 1 in mouse embryonic stem cells directs the differentiation of neuronal precursors and identifies unique patterns of down-stream gene expression. | Velkey JM et al. | β | 2013 | β |
| FOXO3 shares common targets with ASCL1 genome-wide and inhibits ASCL1-dependent neurogenesis. | Webb AE et al. | β | 2013 | β |
| From the Cover: Neutralization of terminal differentiation in gliomagenesis. | Hu J et al. | β | 2013 | β |
| Gene expression alterations in bipolar disorder postmortem brains. | Chen H et al. | β | 2013 | β |
| Generation of induced neurons via direct conversion in vivo. | Torper O et al. | β | 2013 | β |
| Generation of integration-free and region-specific neural progenitors from primate fibroblasts. | Lu J et al. | β | 2013 | β |
| Generation of oligodendroglial cells by direct lineage conversion. | Yang N et al. | β | 2013 | β |
| Hacking cell differentiation: transcriptional rerouting in reprogramming, lineage infidelity and metaplasia. | Regalo G et al. | β | 2013 | β |
| Heart regeneration using reprogramming technology. | Ieda M | β | 2013 | β |
| Hierarchical mechanisms for direct reprogramming of fibroblasts to neurons. | Wapinski OL et al. | β | 2013 | β |
| Identification of a neuronal transcription factor network involved in medulloblastoma development. | Lastowska M et al. | β | 2013 | β |
| Increased gene expression of FOXP1 in patients with autism spectrum disorders. | Chien WH et al. | β | 2013 | β |
| Induced neural stem cells generated from rat fibroblasts. | Xi G et al. | β | 2013 | β |
| Induced neural stem cells (iNSCs) in neurodegenerative diseases. | Hermann A et al. | β | 2013 | β |
| Induced pluripotency and direct reprogramming: a new window for treatment of neurodegenerative diseases. | Li R et al. | β | 2013 | β |
| Induced pluripotent stem cells for spinal cord injury therapy: current status and perspective. | Wang H et al. | β | 2013 | β |
| Induced pluripotent stem cell technology and direct conversion: new possibilities to study and treat Parkinson's disease. | Roessler R et al. | β | 2013 | β |
| Induction of human cardiomyocyte-like cells from fibroblasts by defined factors. | Wada R et al. | β | 2013 | β |
| Leveling Waddington: the emergence of direct programming and the loss of cell fate hierarchies. | Ladewig J et al. | β | 2013 | β |
| Leveling Waddington: the emergence of direct programming and the loss of cell fate hierarchies. | Ladewig J et al. | β | 2013 | β |
| Making steady progress on direct cardiac reprogramming toward clinical application. | Miki K et al. | β | 2013 | β |
| Membrane-tethered monomeric neurexin LNS-domain triggers synapse formation. | Gokce O et al. | β | 2013 | β |
| Modeling schizophrenia using induced pluripotent stem cell-derived and fibroblast-induced neurons. | Tran NN et al. | β | 2013 | β |
| Neural regeneration. | Steward MM et al. | β | 2013 | β |
| Neural stem and progenitor cells in health and disease. | Ladran I et al. | β | 2013 | β |
| Neural stem cell-based treatment for neurodegenerative diseases. | Kim SU et al. | β | 2013 | β |
| Neuron-glia interaction as a possible glue to translate the mind-brain gap: a novel multi-dimensional approach toward psychology and psychiatry. | Kato TA et al. | β | 2013 | β |
| Neurons generated by direct conversion of fibroblasts reproduce synaptic phenotype caused by autism-associated neuroligin-3 mutation. | Chanda S et al. | β | 2013 | β |
| Octamer-binding transcription factors: genomics and functions. | Zhao FQ | β | 2013 | β |
| Oct transcription factors in development and stem cells: insights and mechanisms. | Tantin D | β | 2013 | β |
| Opportunities and challenges of pluripotent stem cell neurodegenerative disease models. | Sandoe J et al. | β | 2013 | β |
| Over-expression of Mash1 improves the GABAergic differentiation of bone marrow mesenchymal stem cells in vitro. | Wang K et al. | β | 2013 | β |
| Progress in the reprogramming of somatic cells. | Ma T et al. | β | 2013 | β |
| Proneural genes in neocortical development. | Wilkinson G et al. | β | 2013 | β |
| Rapid single-step induction of functional neurons from human pluripotent stem cells. | Zhang Y et al. | β | 2013 | β |
| Reciprocal modulation between microglia and astrocyte in reactive gliosis following the CNS injury. | Gao Z et al. | β | 2013 | β |
| Regenerative medicine: challenges and perspectives for successful therapies. | Viswanathan S et al. | β | 2013 | β |
| Remodeling neurodegeneration: somatic cell reprogramming-based models of adult neurological disorders. | Qiang L et al. | β | 2013 | β |
| Reprogramming adult human dermal fibroblasts to islet-like cells by epigenetic modification coupled to transcription factor modulation. | Katz LS et al. | β | 2013 | β |
| Reprogramming and transdifferentiation shift the landscape of regenerative medicine. | Guo J et al. | β | 2013 | β |
| Reprogramming fibroblasts into bipotential hepatic stem cells by defined factors. | Yu B et al. | β | 2013 | β |
| Reprogramming fibroblasts to neural-precursor-like cells by structured overexpression of pallial patterning genes. | Raciti M et al. | β | 2013 | β |
| Reprogramming human fibroblasts to neurons by recapitulating an essential microRNA-chromatin switch. | Tang J et al. | β | 2013 | β |
| Reprogramming of human fibroblasts toward a cardiac fate. | Nam YJ et al. | β | 2013 | β |
| Reprogramming of mouse fibroblasts into cardiomyocyte-like cells in vitro. | Qian L et al. | β | 2013 | β |
| Resetting epigenetic signatures to induce somatic cell reprogramming. | Lluis F et al. | β | 2013 | β |
| Reshaping the brain: direct lineage conversion in the nervous system. | Amamoto R et al. | β | 2013 | β |
| Scalable culture of human pluripotent stem cells in 3D. | McDevitt TC | β | 2013 | β |
| "Seq-ing" insights into the epigenetics of neuronal gene regulation. | Telese F et al. | β | 2013 | β |
| Small molecules enable neurogenin 2 to efficiently convert human fibroblasts into cholinergic neurons. | Liu ML et al. | β | 2013 | β |
| Stem cell therapy: an exercise in patience and prudence. | Lin HT et al. | β | 2013 | β |
| Synaptotagmin-1 and synaptotagmin-7 trigger synchronous and asynchronous phases of neurotransmitter release. | Bacaj T et al. | β | 2013 | β |
| [Target validation strategy in designing novel therapeutics for schizophrenia]. | Yoshimizu T et al. | β | 2013 | β |
| The cellular memory disc of reprogrammed cells. | Anjamrooz SH | β | 2013 | β |
| The mood stabilizer valproate activates human FGF1 gene promoter through inhibiting HDAC and GSK-3 activities. | Kao CY et al. | β | 2013 | β |
| The reprogrammed pancreatic progenitor-like intermediate state of hepatic cells is more susceptible to pancreatic beta cell differentiation. | Wang Q et al. | β | 2013 | β |
| The role of single-cell analyses in understanding cell lineage commitment. | Gibson TM et al. | β | 2013 | β |
| Transcriptional regulation and its misregulation in disease. | Lee TI et al. | β | 2013 | β |
| Transcriptional regulation and specification of neural stem cells. | Christie KJ et al. | β | 2013 | β |
| Transcriptional regulation of the peripheral nervous system in Ciona intestinalis. | Joyce Tang W et al. | β | 2013 | β |
| Transcription factor-mediated reprogramming of fibroblasts to expandable, myelinogenic oligodendrocyte progenitor cells. | Najm FJ et al. | β | 2013 | β |
| Trivalent chromatin marks the way in. | Hysolli E et al. | β | 2013 | β |
| White matter from fibroblasts. | Goldman SA | β | 2013 | β |
| Will brain cells derived from induced pluripotent stem cells or directly converted from somatic cells (iNs) be useful for schizophrenia research? | Filippich C et al. | β | 2013 | β |
| A case of cellular alchemy: lineage reprogramming and its potential in regenerative medicine. | Asuelime GE et al. | β | 2012 | β |
| Accelerating progress in induced pluripotent stem cell research for neurological diseases. | Ito D et al. | β | 2012 | β |
| A good spirit for all seasons. A few highlights with my friend JΓ³ska HΓ‘mori. | Roska T | β | 2012 | β |
| An emerging strategy of gene therapy for cardiac disease. | Yoshida Y et al. | β | 2012 | β |
| Application of reprogrammed patient cells to investigate the etiology of neurological and psychiatric disorders. | Christian KM et al. | β | 2012 | β |
| Cellular reprogramming: a new technology frontier in pharmaceutical research. | Brock A et al. | β | 2012 | β |
| Cellular reprogramming: a novel tool for investigating autism spectrum disorders. | Kim KY et al. | β | 2012 | β |
| Cellular reprogramming: a small molecule perspective. | Nie B et al. | β | 2012 | β |
| Combining topographical and genetic cues to promote neuronal fate specification in stem cells. | Purcell EK et al. | β | 2012 | β |
| Cord blood-derived neuronal cells by ectopic expression of Sox2 and c-Myc. | Giorgetti A et al. | β | 2012 | β |
| Direct conversion in the heart: a simple twist of fate. | DeWitt ND et al. | β | 2012 | β |
| Direct conversion of dermal fibroblasts into neural progenitor cells by a novel cocktail of defined factors. | Tian C et al. | β | 2012 | β |
| Direct conversion of fibroblasts into stably expandable neural stem cells. | Thier M et al. | β | 2012 | β |
| Direct conversion of fibroblasts to functional neurons. | Yashar M et al. | β | 2012 | β |
| Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells. | Lujan E et al. | β | 2012 | β |
| Directed induction of functional motor neuron-like cells from genetically engineered human mesenchymal stem cells. | Park HW et al. | β | 2012 | β |
| Direct lineage conversion: induced neuronal cells and induced neural stem cells. | Shi Z et al. | β | 2012 | β |
| Direct lineage reprogramming to neural cells. | Kim J et al. | β | 2012 | β |
| Direct reprogramming of fibroblasts into neural stem cells by defined factors. | Han DW et al. | β | 2012 | β |
| Direct reprogramming of human astrocytes into neural stem cells and neurons. | Corti S et al. | β | 2012 | β |
| Direct reprogramming of human fibroblasts into dopaminergic neuron-like cells. | Liu X et al. | β | 2012 | β |
| Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor. | Ring KL et al. | β | 2012 | β |
| Dopaminergic differentiation using pluripotent stem cells. | MomΔiloviΔ O et al. | β | 2012 | β |
| Driving apoptosis-relevant proteins toward neural differentiation. | SolΓ‘ S et al. | β | 2012 | β |
| Epigenetics and neurosurgery: editorial marks on the text of life. | Nakaji P et al. | β | 2012 | β |
| Epigenetics of early-life lead exposure and effects on brain development. | Senut MC et al. | β | 2012 | β |
| Functional neuronal cells generated by human parthenogenetic stem cells. | Ahmad R et al. | β | 2012 | β |
| Gene overexpression: uses, mechanisms, and interpretation. | Prelich G | β | 2012 | β |
| Generation and applications of human pluripotent stem cells induced into neural lineages and neural tissues. | Martinez Y et al. | β | 2012 | β |
| Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as an in vitro model and for therapy of muscular dystrophies. | Salani S et al. | β | 2012 | β |
| Genetic and epigenetic determinants of neurogenesis and myogenesis. | Fong AP et al. | β | 2012 | β |
| Glial progenitor cell-based treatment and modeling of neurological disease. | Goldman SA et al. | β | 2012 | β |
| Human-induced pluripotent stem cells: in quest of clinical applications. | Madonna R | β | 2012 | β |
| Induction of fibroblasts to neurons through adenoviral gene delivery. | Meng F et al. | β | 2012 | β |
| Induction of neural differentiation by the transcription factor neuroD2. | Messmer K et al. | β | 2012 | β |
| Investigating schizophrenia in a "dish": possibilities, potential and limitations. | Bray NJ et al. | β | 2012 | β |
| iPS cell technology-based research for the treatment of diabetic nephropathy. | Osafune K | β | 2012 | β |
| Isolation of a novel rat neural progenitor clone that expresses Dlx family transcription factors and gives rise to functional GABAergic neurons in culture. | Li H et al. | β | 2012 | β |
| Labor pains of new technology: direct cardiac reprogramming. | Yoshida Y et al. | β | 2012 | β |
| Lineage conversion methodologies meet the reprogramming toolbox. | Sancho-Martinez I et al. | β | 2012 | β |
| Mesenchymal cell populations: development of the induction systems for Schwann cells and neuronal cells and finding the unique stem cell population. | Kitada M | β | 2012 | β |
| Microarray with micro- and nano-topographies enables identification of the optimal topography for directing the differentiation of primary murine neural progenitor cells. | Moe AA et al. | β | 2012 | β |
| Modeling psychiatric disorders at the cellular and network levels. | Brennand KJ et al. | β | 2012 | β |
| Modeling psychiatric disorders through reprogramming. | Brennand KJ et al. | β | 2012 | β |
| Molecular roadblocks for cellular reprogramming. | Vierbuchen T et al. | β | 2012 | β |
| Morphological and electrophysiological features of mature neurons in differentiated skin-derived precursor cells. | Liebmann L et al. | β | 2012 | β |
| Neural stem cells directly differentiated from partially reprogrammed fibroblasts rapidly acquire gliogenic competency. | Matsui T et al. | β | 2012 | β |
| Neuronal transcription factors induce conversion of human glioma cells to neurons and inhibit tumorigenesis. | Zhao J et al. | β | 2012 | β |
| Nonviral direct conversion of primary mouse embryonic fibroblasts to neuronal cells. | Adler AF et al. | β | 2012 | β |
| Non-Viral Generation of Neural Precursor-like Cells from Adult Human Fibroblasts. | Maucksch C et al. | β | 2012 | β |
| On challenging the prevailing dogma: Nobel prizes and pink diamonds. | Balls M | β | 2012 | β |
| Phylogenomics meets neuroscience: how many times might complex brains have evolved? | Moroz LL | β | 2012 | β |
| Polyglutamine (polyQ) disorders: the chromatin connection. | Cohen-Carmon D et al. | β | 2012 | β |
| Programming and reprogramming neuronal subtypes in the central nervous system. | Rouaux C et al. | β | 2012 | β |
| Proteins reprogramming: present and future. | Yang Y et al. | β | 2012 | β |
| Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives. | Nazor KL et al. | β | 2012 | β |
| Reference genes for high-throughput quantitative reverse transcription-PCR analysis of gene expression in organs and tissues of Eucalyptus grown in various environmental conditions. | Cassan-Wang H et al. | β | 2012 | β |
| Regenerative medicine: Reprogramming the injured heart. | Palpant NJ et al. | β | 2012 | β |
| Regulation of gene expression during early neuronal differentiation: evidence for patterns conserved across neuron populations and vertebrate classes. | Ernsberger U | β | 2012 | β |
| Regulation of synaptic functions in central nervous system by endocrine hormones and the maintenance of energy homoeostasis. | Pang ZP et al. | β | 2012 | β |
| Reprogramming cell fates: insights from combinatorial approaches. | Pereira CF et al. | β | 2012 | β |
| Reprogramming of pericyte-derived cells of the adult human brain into induced neuronal cells. | Karow M et al. | β | 2012 | β |
| Research on neurodegenerative diseases using induced pluripotent stem cells. | Imamura K et al. | β | 2012 | β |
| Reversine promotes porcine muscle derived stem cells (PMDSCs) differentiation into female germ-like cells. | Lv X et al. | β | 2012 | β |
| Small molecules, big roles -- the chemical manipulation of stem cell fate and somatic cell reprogramming. | Zhang Y et al. | β | 2012 | β |
| Small molecules enable highly efficient neuronal conversion of human fibroblasts. | Ladewig J et al. | β | 2012 | β |
| Sox2 acts through Sox21 to regulate transcription in pluripotent and differentiated cells. | Kuzmichev AN et al. | β | 2012 | β |
| Specification of functional neurons and glia from human pluripotent stem cells. | Jiang Y et al. | β | 2012 | β |
| Stem cell models of Alzheimer's disease and related neurological disorders. | Livesey FJ | β | 2012 | β |
| Stem cell repair of striatal ischemia. | Kokaia Z et al. | β | 2012 | β |
| Stem cells and regenerative therapies for Parkinson's disease. | Farrell K et al. | β | 2012 | β |
| Stem cell therapy for cerebral ischemia: from basic science to clinical applications. | Abe K et al. | β | 2012 | β |
| Stem cell transplantation in neurodegenerative disorders of the gastrointestinal tract: future or fiction? | Kulkarni S et al. | β | 2012 | β |
| The path from skin to brain: generation of functional neurons from fibroblasts. | Abdullah AI et al. | β | 2012 | β |
| Transcriptional regulation by coactivators in embryonic stem cells. | Fong YW et al. | β | 2012 | β |
| Transcription factor-mediated epigenetic reprogramming. | Sindhu C et al. | β | 2012 | β |
| Understanding cancer stem cell heterogeneity and plasticity. | Tang DG | β | 2012 | β |
| Understanding the evolution and development of neurosensory transcription factors of the ear to enhance therapeutic translation. | Pan N et al. | β | 2012 | β |
| Zic3 induces conversion of human fibroblasts to stable neural progenitor-like cells. | Kumar A et al. | β | 2012 | β |
| Advancing drug discovery for schizophrenia. | Marder SR et al. | β | 2011 | β |
| Capturing Alzheimer's disease genomes with induced pluripotent stem cells: prospects and challenges. | Israel MA et al. | β | 2011 | β |
| Cellular reprogramming: recent advances in modeling neurological diseases. | Ming GL et al. | β | 2011 | β |
| [Cellular transdifferentiation in amyotrophic lateral sclerosis]. | Nicaise C et al. | β | 2011 | β |
| Comprehensive qPCR profiling of gene expression in single neuronal cells. | Citri A et al. | β | 2011 | β |
| Concise review: alchemy of biology: generating desired cell types from abundant and accessible cells. | Pournasr B et al. | β | 2011 | β |
| Converting human skin cells to neurons: a new tool to study and treat brain disorders? | Kim KS | β | 2011 | β |
| Direct conversion of human fibroblasts to functional neurons in one step. | Berry N et al. | β | 2011 | β |
| Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. | Caiazzo M et al. | β | 2011 | β |
| Direct lineage conversion of terminally differentiated hepatocytes to functional neurons. | Marro S et al. | β | 2011 | β |
| Direct lineage conversions: unnatural but useful? | Vierbuchen T et al. | β | 2011 | β |
| Direct reprogramming of adult human fibroblasts to functional neurons under defined conditions. | Ambasudhan R et al. | β | 2011 | β |
| Ectopic PDX-1 expression directly reprograms human keratinocytes along pancreatic insulin-producing cells fate. | Mauda-Havakuk M et al. | β | 2011 | β |
| Historical origins of transdifferentiation and reprogramming. | Graf T | β | 2011 | β |
| Induced neuronal cells: how to make and define a neuron. | Yang N et al. | β | 2011 | β |
| MYT1L is a candidate gene for intellectual disability in patients with 2p25.3 (2pter) deletions. | Stevens SJ et al. | β | 2011 | β |
| Novel paths towards neural cellular products for neurological disorders. | Daadi MM | β | 2011 | β |
| Pluripotent stem cells for the study of CNS development. | Petros TJ et al. | β | 2011 | β |
| Regenerative medicine: Bespoke cells for the human brain. | Sendtner M | β | 2011 | β |
| Reprogrammed Astrocytes as a Potential Therapy for Neurodegenerative Disorders. | Tian C et al. | β | 2011 | β |
| Setting a highway for converting skin into neurons. | Broccoli V et al. | β | 2011 | β |
| Specification of neuronal and glial subtypes from human pluripotent stem cells. | Liu H et al. | β | 2011 | β |
| Turning skin into dopamine neurons. | Parmar M et al. | β | 2011 | β |